This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
| entity | type | frequency |
|---|---|---|
| diabetes | DISEASE | 2399 |
| glucose | CHEMICAL | 941 |
| covid | ORG | 723 |
| diabetes | DISEASE | 498 |
| diabetic | DISEASE | 394 |
| obesity | DISEASE | 367 |
| t2dm | PERSON | 342 |
| type 2 diabetes | DISEASE | 321 |
| covid 19 | ORG | 311 |
| individuals | TAXON | 301 |
| nafld | ORG | 301 |
| infection | DISEASE | 272 |
| mets | ORG | 252 |
| metabolic syndrome | DISEASE | 228 |
| hypertension | DISEASE | 225 |
| diabetes mellitus | DISEASE | 217 |
| hcq | ORG | 169 |
| cholesterol | CHEMICAL | 161 |
| mice | TAXON | 154 |
| hyperglycemia | DISEASE | 149 |
| curcumin | PERSON | 148 |
| china | GPE | 148 |
| inflammation | DISEASE | 147 |
| sars | DISEASE | 146 |
| coronavirus | TAXON | 142 |
| rats | TAXON | 141 |
| india | GPE | 136 |
| dm | ORG | 125 |
| leptin | PERSON | 124 |
| t1d | DISEASE | 117 |
| t2d | DISEASE | 114 |
| adiponectin | PERSON | 111 |
| sars cov 2 | ORG | 103 |
| nash | ORG | 98 |
| death | DISEASE | 91 |
| curcumin | PERSON | 88 |
| gdm | ORG | 87 |
| human | TAXON | 86 |
| type 2 diabetes mellitus | DISEASE | 86 |
| infections | DISEASE | 83 |
| type 1 diabetes | DISEASE | 82 |
| viral | TAXON | 80 |
| overweight | DISEASE | 79 |
| cov | CHEMICAL | 77 |
| ci | ORG | 76 |
| virus | TAXON | 75 |
| tnf | ORG | 72 |
| hyperglycaemia | DISEASE | 68 |
| metformin | CHEMICAL | 67 |
| wuhan | GPE | 67 |
| angiotensin | CHEMICAL | 65 |
| weight loss | DISEASE | 63 |
| cvd | ORG | 63 |
| ms | ORG | 63 |
| fibrosis | DISEASE | 60 |
| coronavirus disease | DISEASE | 59 |
| cardiovascular disease | DISEASE | 58 |
| igt | ORG | 58 |
| atherosclerosis | DISEASE | 57 |
| hfd | ORG | 57 |
| coronavirus | TAXON | 57 |
| prediabetes | DISEASE | 55 |
| hypoglycaemia | DISEASE | 54 |
| obesity | DISEASE | 53 |
| italy | GPE | 53 |
| glucose | CHEMICAL | 49 |
| weight gain | DISEASE | 47 |
| tb | ORG | 46 |
| pcos | DISEASE | 46 |
| brazil | GPE | 46 |
| hyperglycemia | DISEASE | 43 |
| hdl | ORG | 43 |
| uric acid | CHEMICAL | 42 |
| animals | TAXON | 41 |
| il | ORG | 41 |
| hypertensive | DISEASE | 41 |
| fatty liver disease | DISEASE | 40 |
| dyslipidemia | DISEASE | 40 |
| prevalence | ORG | 40 |
| latin america | LOC | 40 |
| pneumonia | DISEASE | 40 |
| angiotensin | CHEMICAL | 39 |
| hypoglycemia | DISEASE | 38 |
| humans | TAXON | 38 |
| diabetes mellitus | DISEASE | 37 |
| alcohol | CHEMICAL | 36 |
| cad | ORG | 36 |
| animal | TAXON | 34 |
| diabetic | DISEASE | 34 |
| ifg | ORG | 34 |
| metformin | CHEMICAL | 34 |
| triglycerides | CHEMICAL | 34 |
| chronic disease | DISEASE | 34 |
| oxygen | CHEMICAL | 34 |
| triglyceride | CHEMICAL | 34 |
| homocysteine | CHEMICAL | 33 |
| type 2 diabetes | DISEASE | 33 |
| hiv | TAXON | 33 |
| deaths | DISEASE | 32 |
| ckd | DISEASE | 32 |
| glycemia | DISEASE | 32 |
| smoking | CHEMICAL | 32 |
| uk | GPE | 31 |
| steatohepatitis | DISEASE | 31 |
| hydroxychloroquine | CHEMICAL | 30 |
| cancer | DISEASE | 30 |
| hypertension | DISEASE | 30 |
| chronic diseases | DISEASE | 29 |
| idf | CHEMICAL | 29 |
| atp | ORG | 29 |
| liraglutide | CHEMICAL | 29 |
| steatosis | DISEASE | 29 |
| anxiety | DISEASE | 29 |
| ulcers | DISEASE | 28 |
| statins | CHEMICAL | 28 |
| myocardial infarction | DISEASE | 28 |
| glycation | CHEMICAL | 28 |
| ghrelin | PERSON | 28 |
| cardiovascular diseases | DISEASE | 28 |
| dpp | ORG | 27 |
| arbs | CHEMICAL | 27 |
| tg | DISEASE | 27 |
| oc | ORG | 27 |
| wc | GPE | 27 |
| depression | DISEASE | 27 |
| endothelial dysfunction | DISEASE | 27 |
| heart failure | DISEASE | 27 |
| creatinine | CHEMICAL | 27 |
| rat | TAXON | 26 |
| chloroquine | CHEMICAL | 26 |
| bp | ORG | 26 |
| diabetes distress | DISEASE | 25 |
| sars cov | ORG | 25 |
| microalbuminuria | DISEASE | 24 |
| aim | PERSON | 24 |
| mouse | TAXON | 24 |
| human | TAXON | 24 |
| us | GPE | 23 |
| pe | ORG | 23 |
| dpn | ORG | 23 |
| copd | ORG | 23 |
| cgm | ORG | 23 |
| ada | ORG | 23 |
| critically ill | DISEASE | 22 |
| abdominal obesity | DISEASE | 22 |
| ppar | ORG | 22 |
| diabetic retinopathy | DISEASE | 22 |
| ulcer | DISEASE | 22 |
| coronavirus disease | DISEASE | 21 |
| ffa | LOC | 21 |
| metabolic syndrome | DISEASE | 21 |
| hydroxychloroquine | CHEMICAL | 21 |
| ii | ORG | 21 |
| metabolic syndrome | DISEASE | 21 |
| prediabetic | DISEASE | 21 |
| no | CHEMICAL | 21 |
| tuberculosis | DISEASE | 21 |
| type 2 diabetic | DISEASE | 21 |
| pd | ORG | 21 |
| bias | CHEMICAL | 21 |
| stroke | DISEASE | 20 |
| nitric oxide | CHEMICAL | 20 |
| dexamethasone | CHEMICAL | 20 |
| coronary artery disease | DISEASE | 20 |
| bacterial | TAXON | 20 |
| whr | ORG | 20 |
| spain | GPE | 20 |
| mycobacterium | TAXON | 20 |
| europe | LOC | 20 |
| diabetes mellitus | DISEASE | 20 |
| dka | ORG | 20 |
| arb | ORG | 20 |
| bacteria | TAXON | 20 |
| type 2 diabetes | DISEASE | 19 |
| sod | ORG | 19 |
| dyslipidaemia | DISEASE | 19 |
| statin | CHEMICAL | 19 |
| hyperinsulinemia | DISEASE | 18 |
| cardiometabolic multimorbidity | DISEASE | 18 |
| ra | DISEASE | 18 |
| insulin | PERSON | 18 |
| chd | ORG | 18 |
| bmi | ORG | 18 |
| ami | ORG | 18 |
| pioglitazone | CHEMICAL | 18 |
| bs | ORG | 17 |
| aceis | CHEMICAL | 17 |
| comorbidity | DISEASE | 17 |
| mgo | ORG | 17 |
| mets | ORG | 17 |
| gip | ORG | 16 |
| plwd | ORG | 16 |
| mexico | GPE | 16 |
| lmic | ORG | 16 |
| taiwan | GPE | 16 |
| fmd | ORG | 16 |
| dnl | ORG | 16 |
| covid 19 | PERSON | 16 |
| snp | ORG | 16 |
| ages | CHEMICAL | 16 |
| ua | ORG | 16 |
| chronic kidney disease | DISEASE | 16 |
| diabetic complications | DISEASE | 16 |
| fever | DISEASE | 16 |
| glutathione | CHEMICAL | 16 |
| hepatic steatosis | DISEASE | 16 |
| metabolic syndrome mets | ORG | 16 |
| nonalcoholic fatty liver disease | DISEASE | 16 |
| testosterone | CHEMICAL | 16 |
| who | ORG | 16 |
| klebsiella | PERSON | 15 |
| ace inhibitors | CHEMICAL | 15 |
| fpg | ORG | 15 |
| hypoglycemia | PERSON | 15 |
| individuals | TAXON | 15 |
| k | CHEMICAL | 15 |
| nonalcoholic steatohepatitis | LOC | 15 |
| latam | ORG | 15 |
| pa | ORG | 15 |
| hyperuricemia | DISEASE | 15 |
| infectious diseases | DISEASE | 15 |
| metabolic abnormalities | DISEASE | 15 |
| retinopathy | DISEASE | 15 |
| metsy | PERSON | 14 |
| ace | ORG | 14 |
| bnp | ORG | 14 |
| cardiovascular | ORG | 14 |
| cholesterol | CHEMICAL | 14 |
| dr | GPE | 14 |
| hcc | ORG | 14 |
| infection | DISEASE | 14 |
| eu | ORG | 14 |
| tbars | CHEMICAL | 14 |
| carbohydrate | CHEMICAL | 14 |
| metabolic disorders | DISEASE | 14 |
| dengue | DISEASE | 14 |
| diabetic foot | DISEASE | 14 |
| exenatide | CHEMICAL | 14 |
| fatty acid | CHEMICAL | 14 |
| fatty acids | CHEMICAL | 14 |
| usa | GPE | 14 |
| ngt | ORG | 13 |
| akt | PERSON | 13 |
| cop | ORG | 13 |
| dm2 | DISEASE | 13 |
| fld | ORG | 13 |
| gd | ORG | 13 |
| leptin | PERSON | 13 |
| japan | GPE | 13 |
| npdr | ORG | 13 |
| sdma | ORG | 13 |
| tag | ORG | 13 |
| iron | CHEMICAL | 13 |
| overweight obesity | DISEASE | 13 |
| respiratory distress syndrome | DISEASE | 13 |
| viral infections | DISEASE | 13 |
| oxldl | GPE | 13 |
| denmark | GPE | 12 |
| lc | PERSON | 12 |
| homa | PERSON | 12 |
| gsh | CHEMICAL | 12 |
| france | GPE | 12 |
| fto | ORG | 12 |
| bf | GPE | 12 |
| coronavirus disease | DISEASE | 12 |
| crf | DISEASE | 12 |
| cmk | ORG | 12 |
| australia | GPE | 12 |
| mda | ORG | 12 |
| lps | ORG | 12 |
| diabetic nephropathy | DISEASE | 12 |
| mers | DISEASE | 12 |
| hypoxia | GPE | 12 |
| magnesium | ORG | 12 |
| sulfonylurea | ORG | 12 |
| neutrophil | GPE | 12 |
| neuropathy | DISEASE | 12 |
| melioidosis | DISEASE | 12 |
| sitagliptin | ORG | 12 |
| vildagliptin | CHEMICAL | 12 |
| wistar | ORG | 12 |
| roc | GPE | 12 |
| poland | GPE | 12 |
| mice | TAXON | 12 |
| diabetes complications | DISEASE | 11 |
| aims | PERSON | 11 |
| crp | ORG | 11 |
| depression | DISEASE | 11 |
| ec | ORG | 11 |
| niddm | ORG | 11 |
| ros | ORG | 11 |
| sa | ORG | 11 |
| diabetes a | DISEASE | 11 |
| healthy south texas | LOC | 11 |
| ketoacidosis | DISEASE | 11 |
| mmhg | ORG | 11 |
| streptozotocin | CHEMICAL | 11 |
| the international diabetes federation | ORG | 11 |
| type 1 diabetes mellitus | DISEASE | 11 |
| type 2 diabetes t2dm | DISEASE | 11 |
| type 2 diabetes mellitus t2dm | DISEASE | 11 |
| viral infection | DISEASE | 11 |
| vivo | GPE | 11 |
| malaria | DISEASE | 11 |
| isi | ORG | 10 |
| h1n1 | GPE | 10 |
| ifn | ORG | 10 |
| ihd | DISEASE | 10 |
| middle east | LOC | 10 |
| igg | ORG | 10 |
| mody | ORG | 10 |
| msg | ORG | 10 |
| malta | GPE | 10 |
| fgr | ORG | 10 |
| gh | GPE | 10 |
| adiponectin | GPE | 10 |
| diabetic foot | DISEASE | 10 |
| death | DISEASE | 10 |
| chloroquine | CHEMICAL | 10 |
| blood | ORG | 10 |
| ards | GPE | 10 |
| nonalcoholic fatty liver disease | DISEASE | 10 |
| age | CHEMICAL | 10 |
| ag | ORG | 10 |
| acr | ORG | 10 |
| acei | ORG | 10 |
| ace 2 | ORG | 10 |
| ndp | CHEMICAL | 10 |
| macrovascular complications | DISEASE | 10 |
| plasma | ORG | 10 |
| cataract | DISEASE | 10 |
| vaspin | GPE | 10 |
| type 2 diabetes t2d | DISEASE | 10 |
| the american diabetes association | ORG | 10 |
| myriocin | CHEMICAL | 10 |
| lung injury | DISEASE | 10 |
| lipids | CHEMICAL | 10 |
| infected | DISEASE | 10 |
| fed | ORG | 10 |
| diabetes mellitus dm | DISEASE | 10 |
| diabetes community | DISEASE | 10 |
| thrombosis | DISEASE | 10 |
| cardiovascular | GPE | 10 |
| sbp | ORG | 10 |
| candesartan | CHEMICAL | 10 |
| rna | ORG | 10 |
| rygb | ORG | 10 |
| res clin pract | PERSON | 10 |
| portugal | GPE | 10 |
| studie | PERSON | 10 |
| type 2 diabetes mellitus | DISEASE | 10 |
| angiotensin aldosterone | CHEMICAL | 10 |
| apelin | ORG | 10 |
| germany | GPE | 9 |
| rosuvastatin | PERSON | 9 |
| mellitus | TAXON | 9 |
| mers cov | ORG | 9 |
| lp | PERSON | 9 |
| korea | GPE | 9 |
| hcy | PERSON | 9 |
| ht | DISEASE | 9 |
| fibrosis | DISEASE | 9 |
| gspe | ORG | 9 |
| angiotensin ii | CHEMICAL | 9 |
| diabetes a | DISEASE | 9 |
| cardiovascular disease | DISEASE | 9 |
| cov | ORG | 9 |
| cck | ORG | 9 |
| alcohol | CHEMICAL | 9 |
| amp | ORG | 9 |
| chc | ORG | 9 |
| stz | ORG | 9 |
| calcium | CHEMICAL | 9 |
| nicotine | CHEMICAL | 9 |
| coronavirus covid | DISEASE | 9 |
| weight reduction | DISEASE | 9 |
| vitamin d | CHEMICAL | 9 |
| urotensin ii | GPE | 9 |
| superoxide | CHEMICAL | 9 |
| sepsis | DISEASE | 9 |
| pigs | TAXON | 9 |
| overweight obese | DISEASE | 9 |
| viruses | TAXON | 9 |
| ncov | ORG | 9 |
| macrosomia | DISEASE | 9 |
| lactate | CHEMICAL | 9 |
| hyperlipidemia | DISEASE | 9 |
| hyperinsulinaemia | DISEASE | 9 |
| glycine | CHEMICAL | 9 |
| microbiome | TAXON | 9 |
| diseases | DISEASE | 9 |
| pad | ORG | 8 |
| mca | ORG | 8 |
| mmp | ORG | 8 |
| nadph | ORG | 8 |
| nlr | ORG | 8 |
| neutrophil | GPE | 8 |
| puerto rico | GPE | 8 |
| pufa | CHEMICAL | 8 |
| prevotella | PERSON | 8 |
| rhr | ORG | 8 |
| shbg | ORG | 8 |
| irs | ORG | 8 |
| iran | GPE | 8 |
| cgms | ORG | 8 |
| hypoglycaemia | DISEASE | 8 |
| hypertensive | DISEASE | 8 |
| hf | ORG | 8 |
| glp | ORG | 8 |
| ga | ORG | 8 |
| dyslipidemia | GPE | 8 |
| cu | PERSON | 8 |
| cer | ORG | 8 |
| bth | CHEMICAL | 8 |
| ba | GPE | 8 |
| aim to | PERSON | 8 |
| type 1 diabetes | DISEASE | 8 |
| sweden | GPE | 8 |
| osa | ORG | 8 |
| vat | ORG | 8 |
| fructosamine | CHEMICAL | 8 |
| vpa | ORG | 8 |
| triglycerides tg | DISEASE | 8 |
| plaque | DISEASE | 8 |
| pain | DISEASE | 8 |
| organisms | TAXON | 8 |
| organ damage | DISEASE | 8 |
| metabolic diseases | DISEASE | 8 |
| loneliness | DISEASE | 8 |
| liver steatosis | DISEASE | 8 |
| ischemia | DISEASE | 8 |
| helminth | TAXON | 8 |
| fungi | TAXON | 8 |
| niacin | CHEMICAL | 8 |
| estradiol | CHEMICAL | 8 |
| type ii diabetes | DISEASE | 8 |
| diabetic foot ulcer | DISEASE | 8 |
| virus | TAXON | 8 |
| acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 8 |
| alanine | CHEMICAL | 8 |
| biennia | DISEASE | 8 |
| amino acids | CHEMICAL | 8 |
| carbohydrates | CHEMICAL | 8 |
| catecholamine | CHEMICAL | 8 |
| coronavirus pneumonia | DISEASE | 8 |
| diabetes hypertension | DISEASE | 8 |
| honduras | GPE | 7 |
| liver disease | DISEASE | 7 |
| iufd | ORG | 7 |
| inflammation | DISEASE | 7 |
| jordan | GPE | 7 |
| latvia | GPE | 7 |
| lipid | GPE | 7 |
| nkt | ORG | 7 |
| low carb | PERSON | 7 |
| mphr | CHEMICAL | 7 |
| mahlzeiten | PERSON | 7 |
| mycobacterium tuberculosis | CHEMICAL | 7 |
| nk | ORG | 7 |
| nseacs | ORG | 7 |
| htgpos | ORG | 7 |
| hw | ORG | 7 |
| ao | GPE | 7 |
| hg | GPE | 7 |
| cox | ORG | 7 |
| acei | CHEMICAL | 7 |
| adf | ORG | 7 |
| osas | ORG | 7 |
| argentina | GPE | 7 |
| austria | GPE | 7 |
| cmr | ORG | 7 |
| csii | ORG | 7 |
| hdm | ORG | 7 |
| ca | CHEMICAL | 7 |
| doppler | PERSON | 7 |
| egcg | CHEMICAL | 7 |
| england | GPE | 7 |
| fk866 | CHEMICAL | 7 |
| glucagon | GPE | 7 |
| oh d | CHEMICAL | 7 |
| iqr | ORG | 7 |
| overweight | DISEASE | 7 |
| glucose intolerance | DISEASE | 7 |
| hypoglycaemic attacks | DISEASE | 7 |
| lipoproteins | CHEMICAL | 7 |
| lispro | CHEMICAL | 7 |
| malnutrition | DISEASE | 7 |
| mitochondrial dysfunction | DISEASE | 7 |
| ml | PERSON | 7 |
| nephropathy | DISEASE | 7 |
| nonalcoholic steatohepatitis | DISEASE | 7 |
| polydatin | PERSON | 7 |
| proteinuria | DISEASE | 7 |
| sulfonylureas | CHEMICAL | 7 |
| the united states | GPE | 7 |
| the world health organization | ORG | 7 |
| zinc | CHEMICAL | 7 |
| spss | ORG | 7 |
| gout | DISEASE | 7 |
| pulmonary tuberculosis | DISEASE | 7 |
| gestational diabetes | DISEASE | 7 |
| vldl | ORG | 7 |
| se | CHEMICAL | 7 |
| fructose | CHEMICAL | 7 |
| south | LOC | 7 |
| t1dm | GPE | 7 |
| tandem | ORG | 7 |
| testosterone | CHEMICAL | 7 |
| triphala | GPE | 7 |
| tar | PERSON | 7 |
| venezuela | TAXON | 7 |
| depressive | DISEASE | 7 |
| aspart | CHEMICAL | 7 |
| bacterial infections | DISEASE | 7 |
| comorbid | DISEASE | 7 |
| vitamin d | PERSON | 7 |
| glp 1 | ORG | 6 |
| l1 | ORG | 6 |
| jak | ORG | 6 |
| infections | DISEASE | 6 |
| ige | ORG | 6 |
| hepg2 | ORG | 6 |
| hypercholesterolemia | DISEASE | 6 |
| hong kong | GPE | 6 |
| hdl c | ORG | 6 |
| guatemala | GPE | 6 |
| laboratory | GPE | 6 |
| gssg | ORG | 6 |
| lxr | ORG | 6 |
| new york city | GPE | 6 |
| lessons | ORG | 6 |
| mdi | ORG | 6 |
| mdrd | ORG | 6 |
| msg fd | ORG | 6 |
| malondialdehyde | PERSON | 6 |
| myocardin | ORG | 6 |
| new zealand | GPE | 6 |
| oca | ORG | 6 |
| odc | ORG | 6 |
| outcome | ORG | 6 |
| pgf2a | CHEMICAL | 6 |
| ggt | ORG | 6 |
| ppd | ORG | 6 |
| gha | ORG | 6 |
| atorvastatin | ORG | 6 |
| fr1da | DISEASE | 6 |
| bg | ORG | 6 |
| paulo | CHEMICAL | 6 |
| ada alad | ORG | 6 |
| adma | CHEMICAL | 6 |
| ampk | ORG | 6 |
| amr | ORG | 6 |
| ast | ORG | 6 |
| ath | ORG | 6 |
| avp | ORG | 6 |
| american diabetes association | ORG | 6 |
| angiotensin aldosterone | CHEMICAL | 6 |
| animal | TAXON | 6 |
| bai | ORG | 6 |
| bcl 2 | PERSON | 6 |
| fgm | DISEASE | 6 |
| bifidobacterium | LOC | 6 |
| bulgaria | GPE | 6 |
| cdc | ORG | 6 |
| caribbean | LOC | 6 |
| central america | LOC | 6 |
| costa rica | GPE | 6 |
| dag | ORG | 6 |
| dbp | ORG | 6 |
| dcm | DISEASE | 6 |
| djbl | PERSON | 6 |
| dli | ORG | 6 |
| fbs | ORG | 6 |
| pre cov | ORG | 6 |
| autoimmunity | DISEASE | 6 |
| pearson | PERSON | 6 |
| dysglycemia | DISEASE | 6 |
| fenofibrate | CHEMICAL | 6 |
| glucocorticoids | CHEMICAL | 6 |
| glucose ifg | CHEMICAL | 6 |
| hepatitis b | DISEASE | 6 |
| hypertriglyceridemia | DISEASE | 6 |
| incretin | PERSON | 6 |
| inulin | PERSON | 6 |
| irisin | CHEMICAL | 6 |
| lipotoxicity | DISEASE | 6 |
| liver injury | DISEASE | 6 |
| magnesium | CHEMICAL | 6 |
| metabolic disease | DISEASE | 6 |
| mmol l | ORG | 6 |
| necrosis | DISEASE | 6 |
| noncommunicable diseases | DISEASE | 6 |
| obese | DISEASE | 6 |
| overload | DISEASE | 6 |
| phosphate | CHEMICAL | 6 |
| respiratory syndrome coronavirus | DISEASE | 6 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 6 |
| sodium glucose | CHEMICAL | 6 |
| thrombotic | DISEASE | 6 |
| tumor necrosis | DISEASE | 6 |
| visceral obesity | DISEASE | 6 |
| visfatin | CHEMICAL | 6 |
| peru | GPE | 6 |
| vitamin e | CHEMICAL | 6 |
| failure | DISEASE | 6 |
| microvascular disease | DISEASE | 6 |
| diabetic ketoacidosis | DISEASE | 6 |
| arterial stiffness | DISEASE | 6 |
| pneumonia | DISEASE | 6 |
| pubmed | PERSON | 6 |
| diabetic foot ulcers | DISEASE | 6 |
| rds | ORG | 6 |
| re aim | ORG | 6 |
| results | PERSON | 6 |
| roux | PERSON | 6 |
| sibo | PERSON | 6 |
| south texas | LOC | 6 |
| statins | ORG | 6 |
| tc | ORG | 6 |
| tsh | ORG | 6 |
| yakult | ORG | 6 |
| springer nature | ORG | 6 |
| atherosclerotic | DISEASE | 6 |
| coronary heart disease | DISEASE | 6 |
| diabetic cardiomyopathy | DISEASE | 6 |
| diabetes diabetes | DISEASE | 6 |
| cortisone | CHEMICAL | 6 |
| cortisol | CHEMICAL | 6 |
| coronavirus infection | DISEASE | 6 |
| creatine | CHEMICAL | 6 |
| chest pain | DISEASE | 6 |
| cardiometabolic disorders | DISEASE | 6 |
| cardiovascular complications | DISEASE | 6 |
| hg | ORG | 5 |
| ipm | ORG | 5 |
| imt | ORG | 5 |
| il 6 | ORG | 5 |
| iii | ORG | 5 |
| hyperglycaemia | DISEASE | 5 |
| hdlc | ORG | 5 |
| hid | ORG | 5 |
| hbv | ORG | 5 |
| gk | ORG | 5 |
| gs | CHEMICAL | 5 |
| gram | PERSON | 5 |
| international diabetes federation | ORG | 5 |
| iri | ORG | 5 |
| ncep atp iii | ORG | 5 |
| israel | GPE | 5 |
| kontrollgruppe | ORG | 5 |
| la | GPE | 5 |
| lvdd | ORG | 5 |
| lack | PERSON | 5 |
| liraglutide | CHEMICAL | 5 |
| met | DISEASE | 5 |
| mo | GPE | 5 |
| matsuda | ORG | 5 |
| meta | ORG | 5 |
| monaten | PERSON | 5 |
| nd | GPE | 5 |
| gbt | CHEMICAL | 5 |
| netherlands | GPE | 5 |
| gck | ORG | 5 |
| ana | ORG | 5 |
| finland | GPE | 5 |
| covid19 | ORG | 5 |
| pcr | ORG | 5 |
| ac | ORG | 5 |
| adp | ORG | 5 |
| art | ORG | 5 |
| aghdam watson | PERSON | 5 |
| americas | TAXON | 5 |
| ang ii | PERSON | 5 |
| angiotensin ii | PERSON | 5 |
| burkholderia | GPE | 5 |
| burkholderia pseudomallei | DISEASE | 5 |
| cam | ORG | 5 |
| cc | CHEMICAL | 5 |
| ccm | ORG | 5 |
| cv | ORG | 5 |
| fasl | CHEMICAL | 5 |
| chemerin | PERSON | 5 |
| chlamydia | TAXON | 5 |
| chronic | ORG | 5 |
| colombia | GPE | 5 |
| dfd | ORG | 5 |
| dio | ORG | 5 |
| dsg | ORG | 5 |
| delhi | GPE | 5 |
| dengue | GPE | 5 |
| diabetic nephropathy | ORG | 5 |
| epa | ORG | 5 |
| fxr | ORG | 5 |
| DISEASE | 5 | |
| obex | ORG | 5 |
| tumor | DISEASE | 5 |
| pnu | ORG | 5 |
| macrovascular | DISEASE | 5 |
| dying | DISEASE | 5 |
| dysmetabolic syndrome | DISEASE | 5 |
| glutathione gsh | CHEMICAL | 5 |
| hypercholesterolemia | DISEASE | 5 |
| hypothyroid | DISEASE | 5 |
| hypothyroidism | DISEASE | 5 |
| infectious disease | DISEASE | 5 |
| inflammatory rheumatic diseases | DISEASE | 5 |
| insomnia | DISEASE | 5 |
| journal | ORG | 5 |
| lipolysis | DISEASE | 5 |
| lipopolysaccharide | CHEMICAL | 5 |
| liver disease | DISEASE | 5 |
| metabolic disturbances | DISEASE | 5 |
| diabetes mellitus diabetes | DISEASE | 5 |
| methylglyoxal | CHEMICAL | 5 |
| microvascular | ORG | 5 |
| myopathy | DISEASE | 5 |
| peripheral neuropathy | DISEASE | 5 |
| plasma leptin | PERSON | 5 |
| psoriasis | DISEASE | 5 |
| pylori infection | DISEASE | 5 |
| respiratory tract infections | DISEASE | 5 |
| sodium | CHEMICAL | 5 |
| type 1 diabetes t1d | DISEASE | 5 |
| vascular complications | DISEASE | 5 |
| vitro | PERSON | 5 |
| pwv | ORG | 5 |
| diabetic neuropathy | DISEASE | 5 |
| proinsulin | PERSON | 5 |
| diabetes mellitus a | DISEASE | 5 |
| acute respiratory syndrome | DISEASE | 5 |
| preeclampsia | GPE | 5 |
| diabetes diabetes | DISEASE | 5 |
| results | ORG | 5 |
| reddit diabetes | DISEASE | 5 |
| rosi | PERSON | 5 |
| sat | ORG | 5 |
| sc | ORG | 5 |
| sfa | ORG | 5 |
| trimps | ORG | 5 |
| vfa | PERSON | 5 |
| viral | TAXON | 5 |
| acarbose | CHEMICAL | 5 |
| acute myocardial infarction | DISEASE | 5 |
| s1p | CHEMICAL | 5 |
| adiponectine | CHEMICAL | 5 |
| cholesterol triglycerides | CHEMICAL | 5 |
| cough | DISEASE | 5 |
| antidepressant | CHEMICAL | 5 |
| dehydration | DISEASE | 5 |
| colorectal cancer | DISEASE | 5 |
| cirrhosis | DISEASE | 5 |
| chronic illness | DISEASE | 5 |
| clozapine | CHEMICAL | 5 |
| cholesterol triglyceride | CHEMICAL | 5 |
| cancers | DISEASE | 5 |
| camp | CHEMICAL | 5 |
| beta cell dysfunction | DISEASE | 5 |
| aspartate | CHEMICAL | 5 |
| na | ORG | 4 |
| nampt | ORG | 4 |
| lep | ORG | 4 |
| mouse | TAXON | 4 |
| metabolic syndrome mets | DISEASE | 4 |
| melioidosis | DISEASE | 4 |
| maternal | ORG | 4 |
| london | GPE | 4 |
| lithuania | GPE | 4 |
| leto | LOC | 4 |
| immune | LOC | 4 |
| ldn | ORG | 4 |
| ldm | ORG | 4 |
| kuwait | GPE | 4 |
| intensive care unit | ORG | 4 |
| innate | ORG | 4 |
| ivr | ORG | 4 |
| imcl | ORG | 4 |
| il 4 | ORG | 4 |
| iha | ORG | 4 |
| net | ORG | 4 |
| igf | ORG | 4 |
| ncep | GPE | 4 |
| pwv time | ORG | 4 |
| npdr group | ORG | 4 |
| prism | DISEASE | 4 |
| healthcare | ORG | 4 |
| s1pr1 | PERSON | 4 |
| russia | GPE | 4 |
| romania | GPE | 4 |
| renin angiotensin aldosterone system | PERSON | 4 |
| rat | TAXON | 4 |
| rb | ORG | 4 |
| prognosis | ORG | 4 |
| plasma leptin | PERSON | 4 |
| pge | CHEMICAL | 4 |
| nsc | ORG | 4 |
| pci | ORG | 4 |
| omentin | PERSON | 4 |
| ovx | ORG | 4 |
| os | ORG | 4 |
| opg | ORG | 4 |
| ogtt | PERSON | 4 |
| ogl | ORG | 4 |
| north india | LOC | 4 |
| nephropathy | PERSON | 4 |
| hungary | GPE | 4 |
| cfs | ORG | 4 |
| htn | ORG | 4 |
| asia | LOC | 4 |
| cardiovascular disease | DISEASE | 4 |
| candida | TAXON | 4 |
| cancer | ORG | 4 |
| covid infection | DISEASE | 4 |
| ccbs | CHEMICAL | 4 |
| cbg | ORG | 4 |
| belgium | GPE | 4 |
| baseline | ORG | 4 |
| btm | ORG | 4 |
| agatston | ORG | 4 |
| coolsense | ORG | 4 |
| africa | LOC | 4 |
| adipose | ORG | 4 |
| auc | ORG | 4 |
| atg | ORG | 4 |
| ae | PERSON | 4 |
| adipors | CHEMICAL | 4 |
| acei angiotensin | CHEMICAL | 4 |
| abp | ORG | 4 |
| sle | ORG | 4 |
| covidiab | CHEMICAL | 4 |
| cox | PERSON | 4 |
| hie | ORG | 4 |
| fo | CHEMICAL | 4 |
| hhs | ORG | 4 |
| ha | ORG | 4 |
| gruppe | PERSON | 4 |
| greece | GPE | 4 |
| glycation | CHEMICAL | 4 |
| gsis | ORG | 4 |
| gcs | ORG | 4 |
| früherkennung | PERSON | 4 |
| fio | CHEMICAL | 4 |
| fg | ORG | 4 |
| cross | ORG | 4 |
| ffm | ORG | 4 |
| fd | ORG | 4 |
| ecuador | GPE | 4 |
| ehr | ORG | 4 |
| ec dysfunction | DISEASE | 4 |
| diabetic foot ulcers | ORG | 4 |
| diabetes distress | DISEASE | 4 |
| deutschland | GPE | 4 |
| dnp | ORG | 4 |
| se | DISEASE | 4 |
| mop | ORG | 4 |
| sua | CHEMICAL | 4 |
| fungal | TAXON | 4 |
| nausea | DISEASE | 4 |
| murine | TAXON | 4 |
| minocycline | CHEMICAL | 4 |
| microvascular complications | DISEASE | 4 |
| metabolic syndromes | DISEASE | 4 |
| metabolic disorder | DISEASE | 4 |
| lymphopenia | DISEASE | 4 |
| lucidone | CHEMICAL | 4 |
| liver fibrosis | DISEASE | 4 |
| ketosis | DISEASE | 4 |
| islet autoimmunity | DISEASE | 4 |
| ischemic heart disease | DISEASE | 4 |
| ischaemia | DISEASE | 4 |
| intestinal dysbiosis | DISEASE | 4 |
| infectious | DISEASE | 4 |
| infarct | DISEASE | 4 |
| immune dysfunction | DISEASE | 4 |
| hypogonadism | DISEASE | 4 |
| hypercoagulability | DISEASE | 4 |
| hyperandrogenism | DISEASE | 4 |
| host | TAXON | 4 |
| neoplasia | GPE | 4 |
| noninsulin | GPE | 4 |
| pancreatic β | DISEASE | 4 |
| risperidone | CHEMICAL | 4 |
| sus | ORG | 4 |
| vomiting | DISEASE | 4 |
| urinary tract infections | DISEASE | 4 |
| tocilizumab | CHEMICAL | 4 |
| telmisartan | CHEMICAL | 4 |
| sulphonylurea | CHEMICAL | 4 |
| steroid | CHEMICAL | 4 |
| stearate | CHEMICAL | 4 |
| rs12255372 | ORG | 4 |
| rheumatoid arthritis | DISEASE | 4 |
| pentoxifylline | CHEMICAL | 4 |
| respiratory syndrome | DISEASE | 4 |
| respiratory infections | DISEASE | 4 |
| respiratory failure | DISEASE | 4 |
| respiratory disease | DISEASE | 4 |
| pyruvate | CHEMICAL | 4 |
| pyomyositis | DISEASE | 4 |
| prostaglandins | CHEMICAL | 4 |
| potassium | CHEMICAL | 4 |
| peripheral artery disease | DISEASE | 4 |
| fungal infections | DISEASE | 4 |
| type 2 diabetes a | DISEASE | 4 |
| foot disease | DISEASE | 4 |
| ulcers | DISEASE | 4 |
| uaer | ORG | 4 |
| u s | ORG | 4 |
| type 2 diabetes mellitus | DISEASE | 4 |
| tuberculosis | DISEASE | 4 |
| triglyceride | CHEMICAL | 4 |
| tmprss2 | GPE | 4 |
| telmisartan | CHEMICAL | 4 |
| tw | ORG | 4 |
| tgf | ORG | 4 |
| tbr | CHEMICAL | 4 |
| t2dm htn | PERSON | 4 |
| strongyloides stercoralis | TAXON | 4 |
| streptococcus | GPE | 4 |
| steatosis | DISEASE | 4 |
| staphylococcus | LOC | 4 |
| socioeconomic | GPE | 4 |
| sitagliptin | LOC | 4 |
| singapore | GPE | 4 |
| shiraz | GPE | 4 |
| sars coronavirus | TAXON | 4 |
| faeces | TAXON | 4 |
| un | ORG | 4 |
| sea | GPE | 4 |
| wat | ORG | 4 |
| cardiovascular diseases cvd | DISEASE | 4 |
| eclampsia | DISEASE | 4 |
| euglycemia | DISEASE | 4 |
| diet | ORG | 4 |
| diabetic kidney disease | DISEASE | 4 |
| diabetes covid | DISEASE | 4 |
| congestive heart failure | DISEASE | 4 |
| complexity | DISEASE | 4 |
| chemerin | PERSON | 4 |
| cardiovascular morbidity | DISEASE | 4 |
| conflict | DISEASE | 4 |
| cardiovascular damage | DISEASE | 4 |
| adiponectin leptin | PERSON | 4 |
| wochen | PERSON | 4 |
| cardiac arrhythmias | DISEASE | 4 |
| adenosine | CHEMICAL | 4 |
| world health organization | ORG | 4 |
| arrhythmia | DISEASE | 4 |
| À12 | ORG | 4 |
| butanol | CHEMICAL | 4 |
| wang et al | PERSON | 4 |
| low | PERSON | 3 |
| mcallen | ORG | 3 |
| map | ORG | 3 |
| monica | ORG | 3 |
| mpc | ORG | 3 |
| mtt | ORG | 3 |
| mufa | ORG | 3 |
| mva | TAXON | 3 |
| mas | ORG | 3 |
| nfkb | ORG | 3 |
| methods cross | ORG | 3 |
| mg | CHEMICAL | 3 |
| microvascular | GPE | 3 |
| middle east respiratory syndrome | LOC | 3 |
| multivariate | GPE | 3 |
| myriocin | PERSON | 3 |
| n c paulescu | ORG | 3 |
| n dm | ORG | 3 |
| nas | ORG | 3 |
| ng | CHEMICAL | 3 |
| loneliness | DISEASE | 3 |
| iv | ORG | 3 |
| logistic | PERSON | 3 |
| iom | ORG | 3 |
| hyperuricemia | GPE | 3 |
| nph | ORG | 3 |
| hypogonadism | DISEASE | 3 |
| iapp | ORG | 3 |
| ibm | ORG | 3 |
| ifn γ | CHEMICAL | 3 |
| ii dm | ORG | 3 |
| il 10 | ORG | 3 |
| imm | CHEMICAL | 3 |
| iu | GPE | 3 |
| li | CHEMICAL | 3 |
| iugr | DISEASE | 3 |
| indonesia | GPE | 3 |
| irisin | PERSON | 3 |
| lbm | ORG | 3 |
| ld | GPE | 3 |
| ldh | ORG | 3 |
| lox | ORG | 3 |
| latin america cardiovascular | LOC | 3 |
| lazio | LOC | 3 |
| nkg2a | GPE | 3 |
| pio | PERSON | 3 |
| nzo | CHEMICAL | 3 |
| qol | PERSON | 3 |
| rt pcr | PERSON | 3 |
| ra | ORG | 3 |
| receiver | GPE | 3 |
| rosuva | PERSON | 3 |
| sas | ORG | 3 |
| sglt | ORG | 3 |
| shr tg | PERSON | 3 |
| si | GPE | 3 |
| svneo | ORG | 3 |
| sw | ORG | 3 |
| si | PERSON | 3 |
| smart | ORG | 3 |
| social | ORG | 3 |
| sprague dawley | GPE | 3 |
| strandvik | CHEMICAL | 3 |
| studien | ORG | 3 |
| superjami | ORG | 3 |
| são paulo | GPE | 3 |
| humanin | PERSON | 3 |
| rn | ORG | 3 |
| polycystic ovary syndrome pcos | DISEASE | 3 |
| na fe | ORG | 3 |
| peripheral artery disease | DISEASE | 3 |
| nampt | GPE | 3 |
| neuropathy | DISEASE | 3 |
| nutrison advanced diason | ORG | 3 |
| oads | CHEMICAL | 3 |
| odm | ORG | 3 |
| omm | CHEMICAL | 3 |
| osi | ORG | 3 |
| obese | GPE | 3 |
| objectives | GPE | 3 |
| omani | ORG | 3 |
| outcomes | ORG | 3 |
| outcomes in patients with covid 19 | ORG | 3 |
| paa | ORG | 3 |
| pae | ORG | 3 |
| pins | CHEMICAL | 3 |
| ppe | ORG | 3 |
| pten | ORG | 3 |
| pao | ORG | 3 |
| pentoxifylline | CHEMICAL | 3 |
| hyperglycemia hydroxychloroquine | DISEASE | 3 |
| clozapine | CHEMICAL | 3 |
| humalog | CHEMICAL | 3 |
| bks | ORG | 3 |
| bpm | ORG | 3 |
| barone | ORG | 3 |
| bavaria | GPE | 3 |
| beginn | GPE | 3 |
| behandlung | GPE | 3 |
| biguanide | ORG | 3 |
| bis maltolato | PERSON | 3 |
| burden | PERSON | 3 |
| cd4 | GPE | 3 |
| cdl | ORG | 3 |
| cm | ORG | 3 |
| coronado | ORG | 3 |
| covid 19 association | ORG | 3 |
| creb bcl 2 | PERSON | 3 |
| calcium | CHEMICAL | 3 |
| canada | GPE | 3 |
| catecholamine | GPE | 3 |
| chronic disease | DISEASE | 3 |
| clinical characteristics and risk factors for mortality of covid | ORG | 3 |
| bpa | ORG | 3 |
| azithromycin | CHEMICAL | 3 |
| community | DISEASE | 3 |
| atherosclerosis | DISEASE | 3 |
| 2peak | CHEMICAL | 3 |
| 9 4 ae 2 9 | CHEMICAL | 3 |
| aaa | ORG | 3 |
| af | ORG | 3 |
| agtms | ORG | 3 |
| aha | CHEMICAL | 3 |
| aip | ORG | 3 |
| arm | DISEASE | 3 |
| aucglucose | ORG | 3 |
| abdominal obesity | DISEASE | 3 |
| aflibercept | PERSON | 3 |
| aim the | PERSON | 3 |
| ang | PERSON | 3 |
| angiotensin ii | CHEMICAL | 3 |
| antidepressant | CHEMICAL | 3 |
| apgar | ORG | 3 |
| aph1b | CHEMICAL | 3 |
| apigenin | CHEMICAL | 3 |
| associations | ORG | 3 |
| teddy | PERSON | 3 |
| control | ORG | 3 |
| helicobacter | PERSON | 3 |
| epidemiological | ORG | 3 |
| erkrankung | PERSON | 3 |
| estonia | GPE | 3 |
| extremitäten | CHEMICAL | 3 |
| fda | ORG | 3 |
| fev | ORG | 3 |
| fenofibrate | CHEMICAL | 3 |
| frühstadium | CHEMICAL | 3 |
| funnell | ORG | 3 |
| fußulkus | ORG | 3 |
| g6pd | CHEMICAL | 3 |
| g6pd deficiency | DISEASE | 3 |
| gi | ORG | 3 |
| glp1 | ORG | 3 |
| hbp | ORG | 3 |
| hcl | ORG | 3 |
| hdlcholesterol | ORG | 3 |
| hrt | ORG | 3 |
| haiti | GPE | 3 |
| heinonen | PERSON | 3 |
| ergebnisse | GPE | 3 |
| epidemic | DISEASE | 3 |
| covid 19 disease | DISEASE | 3 |
| entwicklung | PERSON | 3 |
| cpeptide | CHEMICAL | 3 |
| czech republic | GPE | 3 |
| dha | CHEMICAL | 3 |
| di | ORG | 3 |
| dm 2 | ORG | 3 |
| dawley | PERSON | 3 |
| deaths | PERSON | 3 |
| dementia | ORG | 3 |
| diabetes obesity | DISEASE | 3 |
| diabetic ketoacidosis | ORG | 3 |
| diagnosis | PERSON | 3 |
| digital | ORG | 3 |
| doogh | ORG | 3 |
| eds | ORG | 3 |
| ema | ORG | 3 |
| esrd | ORG | 3 |
| eurostat | ORG | 3 |
| empagliflozin | CHEMICAL | 3 |
| entstehen | CHEMICAL | 3 |
| tas | ORG | 3 |
| acm | ORG | 3 |
| tlc | ORG | 3 |
| metabolic syndrome metabolic syndrome | DISEASE | 3 |
| interferon gamma | CHEMICAL | 3 |
| ischemic stroke | DISEASE | 3 |
| islet inflammation | DISEASE | 3 |
| kidney disease | DISEASE | 3 |
| kidney injury | DISEASE | 3 |
| lipopolysaccharides | CHEMICAL | 3 |
| macrovascular disease | DISEASE | 3 |
| malignancies | DISEASE | 3 |
| malondialdehyde mda | CHEMICAL | 3 |
| metabolic syndrome diseases | DISEASE | 3 |
| fatalities | DISEASE | 3 |
| microalbuminuric | DISEASE | 3 |
| microbiota | TAXON | 3 |
| middle east | LOC | 3 |
| min | ORG | 3 |
| multimorbidity | DISEASE | 3 |
| myocardial ischemia | DISEASE | 3 |
| necrotic | DISEASE | 3 |
| nicht | CHEMICAL | 3 |
| noncommunicable disease | DISEASE | 3 |
| insulins | CHEMICAL | 3 |
| inflammatory disease | DISEASE | 3 |
| illness | DISEASE | 3 |
| hypertension diabetes | DISEASE | 3 |
| fatty | CHEMICAL | 3 |
| fatty acids ffa | CHEMICAL | 3 |
| fatty liver | DISEASE | 3 |
| fish | TAXON | 3 |
| flash glucose | CHEMICAL | 3 |
| fucoxanthin | CHEMICAL | 3 |
| gangrene | DISEASE | 3 |
| gastrointestinal symptoms | DISEASE | 3 |
| gestational diabetes mellitus gdm | DISEASE | 3 |
| glibenclamide | CHEMICAL | 3 |
| glucagon | ORG | 3 |
| grape seed | CHEMICAL | 3 |
| gut microbiota | PERSON | 3 |
| heart disease | DISEASE | 3 |
| helminth infections | DISEASE | 3 |
| hepatitis b virus infection | DISEASE | 3 |
| hepatocellular carcinoma | DISEASE | 3 |
| human body | TAXON | 3 |
| hypersensitivity | DISEASE | 3 |
| nonhuman primates | TAXON | 3 |
| omentin | CHEMICAL | 3 |
| orlistat | CHEMICAL | 3 |
| the american heart association | ORG | 3 |
| the danish diabetes association | ORG | 3 |
| the diabetes education program | ORG | 3 |
| the middle east | LOC | 3 |
| the western pacific region | LOC | 3 |
| the north east zone | LOC | 3 |
| thiazolidinediones | CHEMICAL | 3 |
| thrombocytosis | DISEASE | 3 |
| thrombophilia | DISEASE | 3 |
| toxicity | DISEASE | 3 |
| trauma | DISEASE | 3 |
| triacylglycerols | CHEMICAL | 3 |
| tumors | DISEASE | 3 |
| type 2 diabetes obesity | DISEASE | 3 |
| typhus | DISEASE | 3 |
| ventricular hypertrophy | DISEASE | 3 |
| viral pneumonia | DISEASE | 3 |
| vitamin d deficiency | CHEMICAL | 3 |
| À11 | ORG | 3 |
| trc | ORG | 3 |
| the chinese center for disease control and prevention | ORG | 3 |
| sucrose | CHEMICAL | 3 |
| osteoprotegerin | PERSON | 3 |
| strokes | DISEASE | 3 |
| outbreaks | TAXON | 3 |
| parasitic | TAXON | 3 |
| pathologies | DISEASE | 3 |
| peripheral arterial disease | DISEASE | 3 |
| plants | TAXON | 3 |
| polycystic ovary syndrome | DISEASE | 3 |
| precocious puberty | DISEASE | 3 |
| prediabetes igt | DISEASE | 3 |
| progesterone | CHEMICAL | 3 |
| quetiapine | CHEMICAL | 3 |
| rabbits | TAXON | 3 |
| reduction in liver fat | DISEASE | 3 |
| respiratory infection | DISEASE | 3 |
| retinopathy nephropathy | DISEASE | 3 |
| rodents | TAXON | 3 |
| rosiglitazone | CHEMICAL | 3 |
| skeletal muscle | DISEASE | 3 |
| steroids | CHEMICAL | 3 |
| sterol | CHEMICAL | 3 |
| fatigue | DISEASE | 3 |
| polyphenols | CHEMICAL | 3 |
| estrogen | CHEMICAL | 3 |
| vildagliptin | CHEMICAL | 3 |
| virus disease | DISEASE | 3 |
| visfatin nampt | PERSON | 3 |
| wg | GPE | 3 |
| wpr | ORG | 3 |
| weight loss | DISEASE | 3 |
| west nile | LOC | 3 |
| wnt | PERSON | 3 |
| zukunft | GPE | 3 |
| zü | CHEMICAL | 3 |
| a7 nachr | ORG | 3 |
| acid | CHEMICAL | 3 |
| acids | CHEMICAL | 3 |
| acute kidney injury | DISEASE | 3 |
| acute myocardial infarction ami | DISEASE | 3 |
| acute respiratory distress syndrome | DISEASE | 3 |
| acute respiratory syndrome coronavirus 2 | DISEASE | 3 |
| adj | ORG | 3 |
| adrenaline | CHEMICAL | 3 |
| albicans | TAXON | 3 |
| viral infections | DISEASE | 3 |
| vergleich zu | DISEASE | 3 |
| amino acid | CHEMICAL | 3 |
| vzv | DISEASE | 3 |
| trigr | ORG | 3 |
| erreicht | CHEMICAL | 3 |
| tt | ORG | 3 |
| ty | GPE | 3 |
| tehran | GPE | 3 |
| telemedicine | PERSON | 3 |
| terminalia | GPE | 3 |
| the diabetes education program | ORG | 3 |
| the world health organization | ORG | 3 |
| thr1160 | PERSON | 3 |
| time | ORG | 3 |
| tocilizumab | CHEMICAL | 3 |
| triglycerides | CHEMICAL | 3 |
| tryglicerides | LOC | 3 |
| type 2 diabetes mellitus a | DISEASE | 3 |
| ucla | ORG | 3 |
| ukpds | ORG | 3 |
| united states | GPE | 3 |
| urotensin ii | ORG | 3 |
| albuminuria | GPE | 3 |
| vegfr | ORG | 3 |
| angiotensin 1 7 | CHEMICAL | 3 |
| diabetic lung | DISEASE | 3 |
| cognitive deficits | DISEASE | 3 |
| colon carcinogenesis | DISEASE | 3 |
| confusion | DISEASE | 3 |
| cord_uid | LOC | 3 |
| coronavirus diseases covid | DISEASE | 3 |
| coronavirus infected pneumonia | DISEASE | 3 |
| cysteine | CHEMICAL | 3 |
| diabetes 9 | DISEASE | 3 |
| diabetes prediabetes | DISEASE | 3 |
| diabetischen | CHEMICAL | 3 |
| cholesterol cc | CHEMICAL | 3 |
| dipyridamole | CHEMICAL | 3 |
| diseases ncds | DISEASE | 3 |
| dog | TAXON | 3 |
| dyspnoea | DISEASE | 3 |
| eating behavior | DISEASE | 3 |
| eine | CHEMICAL | 3 |
| anomalies | DISEASE | 3 |
| endocrine diseases | DISEASE | 3 |
| endocrinopathy | DISEASE | 3 |
| chronic comorbidities | DISEASE | 3 |
| diabetic foot infections | DISEASE | 3 |
| china | GPE | 3 |
| ctni | ORG | 3 |
| aripiprazole | CHEMICAL | 3 |
| celecoxib | CHEMICAL | 3 |
| aorta | GPE | 3 |
| atorvastatin | CHEMICAL | 3 |
| atrial fibrillation | DISEASE | 3 |
| bacteraemia | DISEASE | 3 |
| bacterium | TAXON | 3 |
| behandelten | CHEMICAL | 3 |
| birth injuries | DISEASE | 3 |
| app | ORG | 3 |
| calcitriol | CHEMICAL | 3 |
| carbohydrate dysfunction | DISEASE | 3 |
| cardiac disease | DISEASE | 3 |
| cardiomyopathy | DISEASE | 3 |
| cardiovascular and renal complications | DISEASE | 3 |
| carnitine | CHEMICAL | 3 |
| cafeteria fed | ORG | 3 |
| cat | TAXON | 3 |
| litchman | PERSON | 2 |
| lmgb | LOC | 2 |
| lc ms ms | ORG | 2 |
| ldlr | ORG | 2 |
| ldlcholesterol | ORG | 2 |
| lhrh | ORG | 2 |
| lean | PERSON | 2 |
| low gi | ORG | 2 |
| la | PERSON | 2 |
| lifestyle | LOC | 2 |
| lagb | ORG | 2 |
| linear | ORG | 2 |
| kidney | PERSON | 2 |
| lada mody | DISEASE | 2 |
| kuwaiti | ORG | 2 |
| kupffer | GPE | 2 |
| kumar | PERSON | 2 |
| korotkov | PERSON | 2 |
| kohlenhydraten | PERSON | 2 |
| kidney disease | DISEASE | 2 |
| ketoacidosis | GPE | 2 |
| kenneth | PERSON | 2 |
| kaposi s sarcoma | DISEASE | 2 |
| kaplan meier | PERSON | 2 |
| mac | ORG | 2 |
| kaposi | ORG | 2 |
| luxembourg | GPE | 2 |
| martinez | PERSON | 2 |
| mad | ORG | 2 |
| malappuram | GPE | 2 |
| mediterranean | LOC | 2 |
| kda | ORG | 2 |
| medical research council | ORG | 2 |
| medical care in diabetes 2020 | ORG | 2 |
| mcauley | PERSON | 2 |
| mato grosso | PERSON | 2 |
| matanzas | GPE | 2 |
| mann whitney u | PERSON | 2 |
| mann whitney | PERSON | 2 |
| malondialdehyde mda | PERSON | 2 |
| malnutrition | ORG | 2 |
| majoramputationen | PERSON | 2 |
| maldi | ORG | 2 |
| macrophage | ORG | 2 |
| mrc | ORG | 2 |
| mip | CHEMICAL | 2 |
| mii | ORG | 2 |
| mie | ORG | 2 |
| mers cov infection | DISEASE | 2 |
| mek | PERSON | 2 |
| mdd | ORG | 2 |
| mbi | ORG | 2 |
| mbf | ORG | 2 |
| mao | ORG | 2 |
| kscdc | DISEASE | 2 |
| heparin | CHEMICAL | 2 |
| jiangsu province | GPE | 2 |
| jewish | DISEASE | 2 |
| hyperinsulinemia | PERSON | 2 |
| hyperinsulinaemia | PERSON | 2 |
| hydroxychloroquine sulfate | PERSON | 2 |
| hydrogen | CHEMICAL | 2 |
| human polymorphonuclear neutrophil | TAXON | 2 |
| hubei province | GPE | 2 |
| homocysteinemia | ORG | 2 |
| hiperhomocysteinemia | GPE | 2 |
| hinauszögerung | PERSON | 2 |
| heukjinju hf hj | ORG | 2 |
| herpes zoster | PERSON | 2 |
| hepatocellular carcinoma | DISEASE | 2 |
| hepatitis b | DISEASE | 2 |
| helminth | TAXON | 2 |
| heart failure | DISEASE | 2 |
| healthkick | ORG | 2 |
| havana | GPE | 2 |
| hasanuddin | DISEASE | 2 |
| htgc | PERSON | 2 |
| hsp70 | DISEASE | 2 |
| hsd1 | CHEMICAL | 2 |
| hqrol | ORG | 2 |
| hn | ORG | 2 |
| hm | GPE | 2 |
| melioidosis melioidosis | LOC | 2 |
| hypertension thrombosis kidney failure | DISEASE | 2 |
| hypertriglyceridemia | PERSON | 2 |
| hyperuricamia | PERSON | 2 |
| immune dysfunction | DISEASE | 2 |
| jahre | GPE | 2 |
| ivermectin | ORG | 2 |
| itemid | ORG | 2 |
| italy t2dm | GPE | 2 |
| iraq | GPE | 2 |
| inulin | PERSON | 2 |
| introduction | ORG | 2 |
| intestinal parasitic infections | DISEASE | 2 |
| influenza | ORG | 2 |
| infectious disease | DISEASE | 2 |
| indo | GPE | 2 |
| ijba | PERSON | 2 |
| hypokalemia | ORG | 2 |
| iwgdf | ORG | 2 |
| ivgtt | ORG | 2 |
| il 8 | ORG | 2 |
| il 2 | ORG | 2 |
| il 17 | ORG | 2 |
| igt ifg | ORG | 2 |
| ig | ORG | 2 |
| ifn gamma | CHEMICAL | 2 |
| ids | ORG | 2 |
| ica | ORG | 2 |
| häufigkeit | GPE | 2 |
| mehta | GPE | 2 |
| proteus discover | PERSON | 2 |
| meronem amoxiklav | PERSON | 2 |
| plantar | ORG | 2 |
| philippines | GPE | 2 |
| peripheral arterial disease | DISEASE | 2 |
| pdx 1 | PERSON | 2 |
| patienten innen mit typ 2 | CHEMICAL | 2 |
| pathogenetic | LOC | 2 |
| parasitic helminths | TAXON | 2 |
| panama | GPE | 2 |
| pakistan | GPE | 2 |
| pacific island | LOC | 2 |
| pacific | ORG | 2 |
| ptb | ORG | 2 |
| psc | ORG | 2 |
| prc | GPE | 2 |
| praw | CHEMICAL | 2 |
| pq | ORG | 2 |
| point | CHEMICAL | 2 |
| pn ii | ORG | 2 |
| pkcalpha | ORG | 2 |
| pgf | CHEMICAL | 2 |
| pcr rflp | ORG | 2 |
| pbs | ORG | 2 |
| p2y12 | GPE | 2 |
| p12 | PERSON | 2 |
| oxytomodulin | GPE | 2 |
| oxygen | CHEMICAL | 2 |
| piette | ORG | 2 |
| plasmodium falciparum | TAXON | 2 |
| metap | PERSON | 2 |
| poblations | PERSON | 2 |
| resistin | PERSON | 2 |
| renin | PERSON | 2 |
| ORG | 2 | |
| rats | TAXON | 2 |
| rationale | ORG | 2 |
| randomized | PERSON | 2 |
| ramadan | PERSON | 2 |
| ramachandran | PERSON | 2 |
| raloxifene | CHEMICAL | 2 |
| rin | ORG | 2 |
| rflp | ORG | 2 |
| ree | ORG | 2 |
| re | ORG | 2 |
| rct | ORG | 2 |
| rbd | DISEASE | 2 |
| raas | ORG | 2 |
| quetiapine | PERSON | 2 |
| qt | ORG | 2 |
| psychosocial | ORG | 2 |
| psycho | GPE | 2 |
| pseudomonas aeruginosa | ORG | 2 |
| präventionsstudie | PERSON | 2 |
| hiv infected | DISEASE | 2 |
| prosiect | ORG | 2 |
| prediabetes | LOC | 2 |
| ox | CHEMICAL | 2 |
| osteocalcin oc | ORG | 2 |
| ontario | GPE | 2 |
| oman | GPE | 2 |
| netosis | ORG | 2 |
| ncep atpiii | ORG | 2 |
| nafld fibrosis | CHEMICAL | 2 |
| n terminal | ORG | 2 |
| mü | CHEMICAL | 2 |
| myr met | CHEMICAL | 2 |
| myocardial | ORG | 2 |
| moscow | GPE | 2 |
| mortality | DISEASE | 2 |
| montani | PERSON | 2 |
| mit | GPE | 2 |
| minocycline | ORG | 2 |
| microparticles | GPE | 2 |
| microalbuminuria | PERSON | 2 |
| mgrc | GPE | 2 |
| mgr | ORG | 2 |
| mexico city | GPE | 2 |
| methylglyoxal | ORG | 2 |
| methods a | ORG | 2 |
| metformin use | PERSON | 2 |
| metabolic syndrome mets | ORG | 2 |
| metabolic syndrome ms | LOC | 2 |
| metab syndr | ORG | 2 |
| metab | ORG | 2 |
| metsyn | DISEASE | 2 |
| ng pd | ORG | 2 |
| nkp44 | GPE | 2 |
| nox | CHEMICAL | 2 |
| normoglycaemia | ORG | 2 |
| odgers | CHEMICAL | 2 |
| oxphos | ORG | 2 |
| oop | ORG | 2 |
| ohas | CHEMICAL | 2 |
| oha | ORG | 2 |
| ob | ORG | 2 |
| nutrients doi | PERSON | 2 |
| nrf2 | ORG | 2 |
| notwithstanding | GPE | 2 |
| northeast india | LOC | 2 |
| north east | LOC | 2 |
| nicastrin pen 2 | PERSON | 2 |
| npdr serum | ORG | 2 |
| nicaragua | GPE | 2 |
| nfr2 | GPE | 2 |
| next | ORG | 2 |
| nernst | ORG | 2 |
| negative | ORG | 2 |
| nauru | GPE | 2 |
| national university of singapore singapore singapore 2 university | ORG | 2 |
| national health programs | ORG | 2 |
| nw | GPE | 2 |
| ntd | ORG | 2 |
| nsw australia | ORG | 2 |
| hla | ORG | 2 |
| dt | ORG | 2 |
| hiit | CHEMICAL | 2 |
| covid 19 prevalence | ORG | 2 |
| covid 19 24 | ORG | 2 |
| covid 19 2 | ORG | 2 |
| cmm | ORG | 2 |
| ckd epi | ORG | 2 |
| cescas | ORG | 2 |
| cc cc | CHEMICAL | 2 |
| c2c12 | GPE | 2 |
| c g | ORG | 2 |
| bulgaria malta | GPE | 2 |
| bucharest | ORG | 2 |
| borrelia burgdorferi | TAXON | 2 |
| borrelia | ORG | 2 |
| blocked | PERSON | 2 |
| blastocystis | TAXON | 2 |
| bisphenol a | CHEMICAL | 2 |
| bisphenol | CHEMICAL | 2 |
| bifidobacterium lactobacillus | LOC | 2 |
| benedetta maria bonora | PERSON | 2 |
| belo horizonte brazil data | ORG | 2 |
| behandlung des | PERSON | 2 |
| bedouin | GPE | 2 |
| bassaering | PERSON | 2 |
| bariatric | ORG | 2 |
| background weight | ORG | 2 |
| background obesity | ORG | 2 |
| covid 19 3 | ORG | 2 |
| crmp | CHEMICAL | 2 |
| hif | ORG | 2 |
| cvd metabolic syndrome | ORG | 2 |
| common infections | DISEASE | 2 |
| coa | ORG | 2 |
| clostridium bacteroides | ORG | 2 |
| clinicaltrials | ORG | 2 |
| clerodendrum | GPE | 2 |
| claros | DISEASE | 2 |
| cirrhosis | DISEASE | 2 |
| chronic diseases | DISEASE | 2 |
| chrome | LOC | 2 |
| china prevention | ORG | 2 |
| china clinical | ORG | 2 |
| chile | GPE | 2 |
| chikungunya | TAXON | 2 |
| chellan et al | GPE | 2 |
| challenges | ORG | 2 |
| cenicriviroc | PERSON | 2 |
| celecoxib | CHEMICAL | 2 |
| carotid | PERSON | 2 |
| cardiovasc diabetol | PERSON | 2 |
| cardiology department | ORG | 2 |
| candida albicans | TAXON | 2 |
| candesartan | PERSON | 2 |
| camel | ORG | 2 |
| california | CHEMICAL | 2 |
| cvds | DISEASE | 2 |
| bun | ORG | 2 |
| bps | CHEMICAL | 2 |
| bpv | ORG | 2 |
| bmsd | ORG | 2 |
| ast alt | ORG | 2 |
| asat | ORG | 2 |
| arb losartan | CHEMICAL | 2 |
| arb angiotensin | CHEMICAL | 2 |
| apb | CHEMICAL | 2 |
| aoa | DISEASE | 2 |
| ao ah | ORG | 2 |
| all | DISEASE | 2 |
| al fk866 | ORG | 2 |
| al | ORG | 2 |
| aki | DISEASE | 2 |
| aih | ORG | 2 |
| aic | ORG | 2 |
| ai | GPE | 2 |
| ahi | ORG | 2 |
| adifit | ORG | 2 |
| acei arb | ORG | 2 |
| ace inhibitors arb | CHEMICAL | 2 |
| abi | ORG | 2 |
| abcde | ORG | 2 |
| aa ag | ORG | 2 |
| 2302 | CHEMICAL | 2 |
| 140 | DISEASE | 2 |
| 104 | ORG | 2 |
| results based | PERSON | 2 |
| atpiii | ORG | 2 |
| aucinsulin | ORG | 2 |
| abs | PERSON | 2 |
| apelin | PERSON | 2 |
| bmi the | ORG | 2 |
| bdnf | PERSON | 2 |
| axis | DISEASE | 2 |
| ausweitung | GPE | 2 |
| ausmaß | GPE | 2 |
| atemwegsinfekte | ORG | 2 |
| association | ORG | 2 |
| arterial stiffness | DISEASE | 2 |
| arabia | TAXON | 2 |
| apolipoprotein | PERSON | 2 |
| aph1b c | CHEMICAL | 2 |
| anthropometric | PERSON | 2 |
| acanthamoeba | GPE | 2 |
| animals | TAXON | 2 |
| angiotensin i | CHEMICAL | 2 |
| analysis | LOC | 2 |
| algorithmus | ORG | 2 |
| albuminuria | GPE | 2 |
| akkermansia | GPE | 2 |
| aims consumption | PERSON | 2 |
| african caribbean | ORG | 2 |
| adipocyte | PERSON | 2 |
| addressing | ORG | 2 |
| ace2 | GPE | 2 |
| common infections | DISEASE | 2 |
| comorbid diabetes | DISEASE | 2 |
| conclusions patients | ORG | 2 |
| enfermedad | GPE | 2 |
| forouzandeh | GPE | 2 |
| first nations | ORG | 2 |
| fibromax | ORG | 2 |
| fe 2 | ORG | 2 |
| fe | CHEMICAL | 2 |
| fas | PERSON | 2 |
| faecalibacterium | ORG | 2 |
| fvg | ORG | 2 |
| fsh | ORG | 2 |
| fsfi | ORG | 2 |
| fpg 2 | ORG | 2 |
| fkb | ORG | 2 |
| findrisk | ORG | 2 |
| ffa adiponectin | CHEMICAL | 2 |
| fasn | ORG | 2 |
| fabppm | CHEMICAL | 2 |
| f | GPE | 2 |
| european medicines agency | ORG | 2 |
| european commission | ORG | 2 |
| ethiopia | GPE | 2 |
| escherichia | PERSON | 2 |
| erythrocyte | ORG | 2 |
| ernährung | PERSON | 2 |
| epac | GPE | 2 |
| entwicklungen | ORG | 2 |
| fußgeschwüre | GPE | 2 |
| gad | ORG | 2 |
| gbd | ORG | 2 |
| glycated | PERSON | 2 |
| hgp | ORG | 2 |
| hbv co infection | DISEASE | 2 |
| gâr | PERSON | 2 |
| gut | PERSON | 2 |
| guias alad | PERSON | 2 |
| group ii | ORG | 2 |
| group b | PERSON | 2 |
| group a | ORG | 2 |
| goto kakizaki gk | PERSON | 2 |
| ORG | 2 | |
| glycemic | ORG | 2 |
| glycaemia | PERSON | 2 |
| gbp | ORG | 2 |
| glutathione | CHEMICAL | 2 |
| ghana | GPE | 2 |
| gait | LOC | 2 |
| gwg | ORG | 2 |
| gtp | ORG | 2 |
| gsk 3beta | CHEMICAL | 2 |
| gppaq | ORG | 2 |
| gm | ORG | 2 |
| gigd | ORG | 2 |
| ggtp | ORG | 2 |
| gg | ORG | 2 |
| enterococcus faecalis staphylococcus | ORG | 2 |
| egypt | GPE | 2 |
| cook | GPE | 2 |
| edelman | ORG | 2 |
| dengue virus | TAXON | 2 |
| daten | CHEMICAL | 2 |
| dalmas | GPE | 2 |
| dxa | ORG | 2 |
| dmh | ORG | 2 |
| dmard | CHEMICAL | 2 |
| dm diabetes mellitus | DISEASE | 2 |
| dm group ii | ORG | 2 |
| dgep | ORG | 2 |
| dexa | ORG | 2 |
| dds2 | ORG | 2 |
| dcfhda | ORG | 2 |
| da | ORG | 2 |
| cushing s disease | DISEASE | 2 |
| cushing | ORG | 2 |
| curcuminoids | CHEMICAL | 2 |
| curcumin a | CHEMICAL | 2 |
| curcuma | GPE | 2 |
| cu cr | PERSON | 2 |
| cryptosporidium parvum | TAXON | 2 |
| cristelo cecília | ORG | 2 |
| covid 19 renin | ORG | 2 |
| correlation | ORG | 2 |
| coronavirus infection | DISEASE | 2 |
| coronaviridae | ORG | 2 |
| dennoch | GPE | 2 |
| der diabetologe | PERSON | 2 |
| der referent | ORG | 2 |
| dietary | ORG | 2 |
| east asia | LOC | 2 |
| emr | PERSON | 2 |
| elisa data | ORG | 2 |
| elisa | ORG | 2 |
| ei | DISEASE | 2 |
| egp | ORG | 2 |
| ecs | ORG | 2 |
| ecg | ORG | 2 |
| dysglykämie | PERSON | 2 |
| doratoxylon | GPE | 2 |
| discussion malnutrition | ORG | 2 |
| diabetologists | ORG | 2 |
| dexcom | ORG | 2 |
| diabetologe doi | PERSON | 2 |
| diabetol | CHEMICAL | 2 |
| diabetic retinopathy | DISEASE | 2 |
| diabetic peripheral neuropathy | DISEASE | 2 |
| diabetesinzidenz | PERSON | 2 |
| diabetes mellitus dm | DISEASE | 2 |
| diabetes mellitus diabetes | DISEASE | 2 |
| diabetes ifd | DISEASE | 2 |
| diabetes education program | ORG | 2 |
| diabetes diabetes | DISEASE | 2 |
| diabet med doi | PERSON | 2 |
| respiratory distress syndrome | DISEASE | 2 |
| nitrous oxide | CHEMICAL | 2 |
| results fasting | PERSON | 2 |
| neuroinflammation | DISEASE | 2 |
| nanoparticles | CHEMICAL | 2 |
| na | CHEMICAL | 2 |
| myocardial injury | DISEASE | 2 |
| myocardial infarction stroke | DISEASE | 2 |
| muscle mass | DISEASE | 2 |
| multiple myeloma | DISEASE | 2 |
| multi organ failure | DISEASE | 2 |
| morbid obesity | DISEASE | 2 |
| monosodium | CHEMICAL | 2 |
| ml min | PERSON | 2 |
| mitochondrial disorders | DISEASE | 2 |
| mit | ORG | 2 |
| microbes | TAXON | 2 |
| methotrexate | CHEMICAL | 2 |
| metabolic syndrome ms | LOC | 2 |
| metabolic syndrom | DISEASE | 2 |
| metabolic overload | DISEASE | 2 |
| metabolic impairments | DISEASE | 2 |
| metabolic endotoxemia | DISEASE | 2 |
| metabolic dysregulation | DISEASE | 2 |
| metabolic dysfunction | DISEASE | 2 |
| metabolic complications | DISEASE | 2 |
| metabolic alterations | DISEASE | 2 |
| melioidosis bacteremia | PERSON | 2 |
| maltodextrin | CHEMICAL | 2 |
| necrobiosis | DISEASE | 2 |
| nicotinamide | CHEMICAL | 2 |
| picolinate berberine | CHEMICAL | 2 |
| nifuroxazide | CHEMICAL | 2 |
| phentermine | CHEMICAL | 2 |
| periodontitis | DISEASE | 2 |
| papillomavirus virus hpv 9 | TAXON | 2 |
| panic | DISEASE | 2 |
| pancreatic beta | DISEASE | 2 |
| palmitic acid | CHEMICAL | 2 |
| palmitate | CHEMICAL | 2 |
| osteocalcin | CHEMICAL | 2 |
| organ failure | DISEASE | 2 |
| oltipraz | CHEMICAL | 2 |
| oligomenorrhea | DISEASE | 2 |
| oleate | CHEMICAL | 2 |
| occult organ damage | DISEASE | 2 |
| obesity metabolic syndrome | DISEASE | 2 |
| obesity dyslipidemia | DISEASE | 2 |
| obesity diabetes | DISEASE | 2 |
| obesity obesity | DISEASE | 2 |
| obese bmi | ORG | 2 |
| nucleotides | CHEMICAL | 2 |
| nucleotide | CHEMICAL | 2 |
| normoalbuminuric | DISEASE | 2 |
| normoalbuminuria microalbuminuria | PERSON | 2 |
| normoalbuminuria | DISEASE | 2 |
| norepinephrine epinephrine | PERSON | 2 |
| nonalcoholic fatty liver disease nafld | DISEASE | 2 |
| malondialdehyde | PERSON | 2 |
| malaria infection | DISEASE | 2 |
| m5f | GPE | 2 |
| lung damage | DISEASE | 2 |
| hypertension dyslipidemia | DISEASE | 2 |
| hypertension cardiovascular disease | DISEASE | 2 |
| hyperphagia | DISEASE | 2 |
| hyperlipidaemia | DISEASE | 2 |
| hyperhomocysteinemia | DISEASE | 2 |
| hyperglycemia dyslipidemia | DISEASE | 2 |
| hyperemia | DISEASE | 2 |
| hyperandrogenemia | DISEASE | 2 |
| hydrogen sulfide | CHEMICAL | 2 |
| humanin | CHEMICAL | 2 |
| human respiratory disease | DISEASE | 2 |
| human preadipocytes | TAXON | 2 |
| human herpesvirus | TAXON | 2 |
| human hepatocytes | TAXON | 2 |
| human coronaviruses | TAXON | 2 |
| hepatosteatosis | DISEASE | 2 |
| hepatitis c | DISEASE | 2 |
| hepatitis | DISEASE | 2 |
| heparin | CHEMICAL | 2 |
| hemolysis | DISEASE | 2 |
| heart disease myocardial infarction | DISEASE | 2 |
| heart diabetes | DISEASE | 2 |
| grain | DISEASE | 2 |
| glycerol | CHEMICAL | 2 |
| glutamate | CHEMICAL | 2 |
| hypertrigliceridemia | DISEASE | 2 |
| hypertriglyceridaemia | DISEASE | 2 |
| hyperuricamia | DISEASE | 2 |
| ketone | CHEMICAL | 2 |
| lung cancer | DISEASE | 2 |
| long qt syndrome | DISEASE | 2 |
| liver failure | DISEASE | 2 |
| liver cirrhosis | DISEASE | 2 |
| leucine | CHEMICAL | 2 |
| lectin | PERSON | 2 |
| lambs | TAXON | 2 |
| lactulose | CHEMICAL | 2 |
| lactic acidosis | DISEASE | 2 |
| lu ml | PERSON | 2 |
| kidney failure | DISEASE | 2 |
| ischaemic heart disease | DISEASE | 2 |
| hyperuricemic | DISEASE | 2 |
| insulin deficiency | DISEASE | 2 |
| insulin | CHEMICAL | 2 |
| influenza a h1n1 infection | DISEASE | 2 |
| infection diabetes | DISEASE | 2 |
| infected diabetic foot | DISEASE | 2 |
| inequality | DISEASE | 2 |
| indomethacin | CHEMICAL | 2 |
| hypokalemia | DISEASE | 2 |
| hypokalaemia | DISEASE | 2 |
| hypoglycemic attacks | DISEASE | 2 |
| hypofibrinolysis | DISEASE | 2 |
| phenylalanine | CHEMICAL | 2 |
| piperine | CHEMICAL | 2 |
| glucose triglycerides | CHEMICAL | 2 |
| type 2 diabetes diabetes | DISEASE | 2 |
| type 1 diabetes diabetes distress | DISEASE | 2 |
| tumour necrosis | DISEASE | 2 |
| tropicalis | TAXON | 2 |
| trophoblast invasion | DISEASE | 2 |
| trihydroxyindole | CHEMICAL | 2 |
| triglycerides cholesterol | CHEMICAL | 2 |
| tissue damage | DISEASE | 2 |
| thrombus | DISEASE | 2 |
| thrombocytopenia | GPE | 2 |
| threonine | CHEMICAL | 2 |
| thiobarbituric acid | CHEMICAL | 2 |
| thiazide | CHEMICAL | 2 |
| the west zone | LOC | 2 |
| the north zone | LOC | 2 |
| the north east | LOC | 2 |
| the national health service | ORG | 2 |
| the american association of clinical endocrinologists | ORG | 2 |
| the world health organization who | ORG | 2 |
| the world health organisation | ORG | 2 |
| the university of lincoln | ORG | 2 |
| the university hospital of padova | ORG | 2 |
| the united kingdom | GPE | 2 |
| the u s | GPE | 2 |
| the thai comprehensive cirs | ORG | 2 |
| the romanian national authority for scientific research | ORG | 2 |
| type 2 diabetes | DISEASE | 2 |
| type 2 diabetes mellitus type 2 diabetes | DISEASE | 2 |
| pneumonitis | DISEASE | 2 |
| type ii dm | DISEASE | 2 |
| zebrafish | TAXON | 2 |
| results mean | PERSON | 2 |
| yeast | TAXON | 2 |
| wuhan | GPE | 2 |
| west zone | GPE | 2 |
| vivax malaria | DISEASE | 2 |
| vivax | TAXON | 2 |
| vitamin b6 | CHEMICAL | 2 |
| vitd deficiency insufficiency | DISEASE | 2 |
| virus infection | DISEASE | 2 |
| virus disease | DISEASE | 2 |
| viral genome | TAXON | 2 |
| viral disease | DISEASE | 2 |
| vildagliptin metformin | PERSON | 2 |
| vessel disease | DISEASE | 2 |
| ventricular tachycardia | DISEASE | 2 |
| ventricular arrhythmia | DISEASE | 2 |
| vasculopathy | DISEASE | 2 |
| vascular injury | DISEASE | 2 |
| vascular inflammation | DISEASE | 2 |
| vascular dysfunction | DISEASE | 2 |
| vascular disease | DISEASE | 2 |
| vascular damage | DISEASE | 2 |
| ulcers infection | DISEASE | 2 |
| tyrosine | CHEMICAL | 2 |
| the queensland university of technology qut | ORG | 2 |
| the national cholesterol education program adult treatment panel iii | ORG | 2 |
| the national cholesterol education program | ORG | 2 |
| the european union | ORG | 2 |
| rheumatic diseases | DISEASE | 2 |
| respiratory syndrome coronavirus mers | DISEASE | 2 |
| resistin | PERSON | 2 |
| renin angiotensin | PERSON | 2 |
| renal dysfunction | DISEASE | 2 |
| renal damage | DISEASE | 2 |
| renal affection | DISEASE | 2 |
| rat chow | TAXON | 2 |
| rapamycin | CHEMICAL | 2 |
| randomisierten | CHEMICAL | 2 |
| raloxifene | CHEMICAL | 2 |
| pyogenic liver abscess | DISEASE | 2 |
| purulent necrotic | DISEASE | 2 |
| pulmonary injury | DISEASE | 2 |
| pseudomallei | TAXON | 2 |
| protonophore | CHEMICAL | 2 |
| proteinuric | DISEASE | 2 |
| propranolol | CHEMICAL | 2 |
| primary language | DISEASE | 2 |
| preeclampsia | DISEASE | 2 |
| prandial | CHEMICAL | 2 |
| polyunsaturated fatty acids | CHEMICAL | 2 |
| polyunsaturated | CHEMICAL | 2 |
| polyphenol | CHEMICAL | 2 |
| polycystic ovary syndrome pcos | DISEASE | 2 |
| rodent | TAXON | 2 |
| rodent chow | TAXON | 2 |
| rs12255372g t | CHEMICAL | 2 |
| steatohepatitis nash | DISEASE | 2 |
| the european guidelines on cardiovascular disease prevention | ORG | 2 |
| the ethics committee | ORG | 2 |
| the ethical committee of the university hospital of padova | ORG | 2 |
| the ethical committee of umberto i policlinico general hospital | ORG | 2 |
| the blue mountains eye study | ORG | 2 |
| the asia pacific | LOC | 2 |
| thcy | ORG | 2 |
| systolic impairment | DISEASE | 2 |
| systolic and diastolic blood pressure | DISEASE | 2 |
| syncytial virus | TAXON | 2 |
| stress anxiety | DISEASE | 2 |
| statisticaly | DISEASE | 2 |
| rs712221 | ORG | 2 |
| sphingosine | CHEMICAL | 2 |
| social stigma | DISEASE | 2 |
| sleep apnea syndrome | DISEASE | 2 |
| sleep apnea | DISEASE | 2 |
| sich | DISEASE | 2 |
| self injury | DISEASE | 2 |
| sec | ORG | 2 |
| schistosomiasis | DISEASE | 2 |
| svcam | CHEMICAL | 2 |
| sfasl | CHEMICAL | 2 |
| scd40l | CHEMICAL | 2 |
| glucose uric acid | CHEMICAL | 2 |
| the world bank | ORG | 2 |
| glucose impairment | DISEASE | 2 |
| teilnehmer innen | ORG | 2 |
| wt | ORG | 2 |
| whtr | ORG | 2 |
| wcm | ORG | 2 |
| wbc | ORG | 2 |
| vitamins a c | ORG | 2 |
| vitamin e | CHEMICAL | 2 |
| vitamin d deficiency | CHEMICAL | 2 |
| visfatin | GPE | 2 |
| viruses | TAXON | 2 |
| verständnis | PERSON | 2 |
| verlauf | PERSON | 2 |
| vaspin | GPE | 2 |
| vntr | ORG | 2 |
| vigitel | ORG | 2 |
| uric acid | CHEMICAL | 2 |
| urea | PERSON | 2 |
| utis | DISEASE | 2 |
| uti | GPE | 2 |
| uefiscdi | ORG | 2 |
| type 1 diabetes | DISEASE | 2 |
| tuberculosis tb | ORG | 2 |
| toxoplasma gondii | TAXON | 2 |
| toxoplasma | ORG | 2 |
| therapien | ORG | 2 |
| therapie | GPE | 2 |
| warburg | GPE | 2 |
| weight loss | DISEASE | 2 |
| weight loss medications on hepatic steatosis | ORG | 2 |
| acromegaly | DISEASE | 2 |
| alcoholic steatohepatitis | DISEASE | 2 |
| alcoholic liver disease | DISEASE | 2 |
| adipose | GPE | 2 |
| adiponectin ghrelin | PERSON | 2 |
| adiponectin triphala | PERSON | 2 |
| adenovirus | TAXON | 2 |
| adenoma | DISEASE | 2 |
| acylcarnitines | CHEMICAL | 2 |
| acute renal failure | DISEASE | 2 |
| acute illness | DISEASE | 2 |
| acute coronary syndrome | DISEASE | 2 |
| acidosis | DISEASE | 2 |
| wilcoxon | ORG | 2 |
| abscesses | DISEASE | 2 |
| abdominal obesity ao | DISEASE | 2 |
| zusammenarbeit | GPE | 2 |
| zn | PERSON | 2 |
| zellen | GPE | 2 |
| wuhan city hubei province | GPE | 2 |
| wuhan city | GPE | 2 |
| wuhan china glycemic | ORG | 2 |
| world health organization coronavirus | ORG | 2 |
| workshop | PERSON | 2 |
| wilcoxon signed ranks | ORG | 2 |
| tharkar | PERSON | 2 |
| tpo | ORG | 2 |
| aldosterone | CHEMICAL | 2 |
| tdd | CHEMICAL | 2 |
| secretagogin | ORG | 2 |
| seattlearea | GPE | 2 |
| saudi arabia | GPE | 2 |
| sao paulo | GPE | 2 |
| sacred heart rome italy | DISEASE | 2 |
| sugarspin | ORG | 2 |
| sugar handshake | ORG | 2 |
| spt | ORG | 2 |
| spb | ORG | 2 |
| solar | ORG | 2 |
| sl | ORG | 2 |
| sh | ORG | 2 |
| scgn | ORG | 2 |
| scd1 | CHEMICAL | 2 |
| sbp dbp | PERSON | 2 |
| sars cov infection | DISEASE | 2 |
| sars cov mers cov | ORG | 2 |
| sabe | ORG | 2 |
| rotterdam | PERSON | 2 |
| rotavirenimpfungso | LOC | 2 |
| rodent | TAXON | 2 |
| results prevalence | PERSON | 2 |
| results overweight | PERSON | 2 |
| glucose hypertriglyceridemia | CHEMICAL | 2 |
| results plasma | PERSON | 2 |
| serum leptin | PERSON | 2 |
| shapiro wilk | PERSON | 2 |
| shirota | ORG | 2 |
| studienpatienten | PERSON | 2 |
| tcr | CHEMICAL | 2 |
| tac | CHEMICAL | 2 |
| t2dm obesity | ORG | 2 |
| t2dm gdm | PERSON | 2 |
| sydney sydney | ORG | 2 |
| sydney australia | ORG | 2 |
| swine flu | TAXON | 2 |
| surrosense | CHEMICAL | 2 |
| sundhedsstyrelsen alle | PERSON | 2 |
| sulfonylurea | PERSON | 2 |
| studies | ORG | 2 |
| strengths | PERSON | 2 |
| siemens | ORG | 2 |
| strandvik 2015 | ORG | 2 |
| steinsbekk | ORG | 2 |
| spilberger | ORG | 2 |
| space | TAXON | 2 |
| southern india | LOC | 2 |
| southeast asia | LOC | 2 |
| south wales | GPE | 2 |
| south india | LOC | 2 |
| smoking | CHEMICAL | 2 |
| slovenia | GPE | 2 |
| skandinavia | GPE | 2 |
| alcoholic steatohepatitis nash | DISEASE | 2 |
| sepsis | DISEASE | 2 |
| allergic diseases | DISEASE | 2 |
| dithiolethione | CHEMICAL | 2 |
| dietician rd | ORG | 2 |
| diesem | DISEASE | 2 |
| diarrhoea | DISEASE | 2 |
| diabetic s | DISEASE | 2 |
| diabetic retinopathy npdr | DISEASE | 2 |
| diabetic overweight | DISEASE | 2 |
| diabetic obese | DISEASE | 2 |
| diabetic foot ulceration | DISEASE | 2 |
| diabetic comorbidities | DISEASE | 2 |
| diabetic tb | DISEASE | 2 |
| diabetes obesity | DISEASE | 2 |
| diabetes mellitus t2dm | DISEASE | 2 |
| diabetes infected | DISEASE | 2 |
| diabetes dyslipidemia hypertension | DISEASE | 2 |
| diabetes comorbidities | DISEASE | 2 |
| diabetes cardiovascular disease | DISEASE | 2 |
| diabetes methylglyoxal | DISEASE | 2 |
| diabetes hyperglycemia | DISEASE | 2 |
| des typ 1 | CHEMICAL | 2 |
| dengue fever | DISEASE | 2 |
| demethoxycurcumin | CHEMICAL | 2 |
| decompensation | DISEASE | 2 |
| daytime sleepiness | DISEASE | 2 |
| dapagliflozin | CHEMICAL | 2 |
| coronavirus sars cov | DISEASE | 2 |
| dimethylarginine | CHEMICAL | 2 |
| docosahexaenoic acids | CHEMICAL | 2 |
| coronary stenosis | DISEASE | 2 |
| dopamine | CHEMICAL | 2 |
| glucose fg | CHEMICAL | 2 |
| glucose abnormalities | DISEASE | 2 |
| amiodarone | CHEMICAL | 2 |
| glucoregulation disorders | DISEASE | 2 |
| gluconeogenesis | CHEMICAL | 2 |
| gliflozins | CHEMICAL | 2 |
| giardia lamblia | TAXON | 2 |
| gestational diabetes mellitus | DISEASE | 2 |
| gallstones | DISEASE | 2 |
| gain | DISEASE | 2 |
| fibrosis cirrhosis | DISEASE | 2 |
| fibrate | CHEMICAL | 2 |
| fetal loss | DISEASE | 2 |
| ferritin | PERSON | 2 |
| fatty liver steatosis | DISEASE | 2 |
| fatty acids ffas | CHEMICAL | 2 |
| ethanol | CHEMICAL | 2 |
| etablierte | GPE | 2 |
| esterified fatty acids | CHEMICAL | 2 |
| endotoxemia | DISEASE | 2 |
| endothelium dysfunction | DISEASE | 2 |
| endotheliitis | DISEASE | 2 |
| eicosapentaenoic | CHEMICAL | 2 |
| dzm4xi21 | PERSON | 2 |
| dysglycaemia | DISEASE | 2 |
| coronavirus 2019 covid | DISEASE | 2 |
| fatty acids scfa | CHEMICAL | 2 |
| coronary microangiopathy | DISEASE | 2 |
| calprotectin | CHEMICAL | 2 |
| brain damage | DISEASE | 2 |
| bradycardia | DISEASE | 2 |
| bloodstream | TAXON | 2 |
| blindness | DISEASE | 2 |
| bisdemethoxycurcumin | CHEMICAL | 2 |
| befruchten | CHEMICAL | 2 |
| bacteriuria | DISEASE | 2 |
| bacterial infection | DISEASE | 2 |
| azithromycin | CHEMICAL | 2 |
| autoimmune reaction | DISEASE | 2 |
| autoimmune diseases | DISEASE | 2 |
| autoimmune diabetes | DISEASE | 2 |
| atherothrombotic | DISEASE | 2 |
| atherosclerotic plaque | DISEASE | 2 |
| atherosclerotic lesion | DISEASE | 2 |
| ascaris lumbricoides | TAXON | 2 |
| artery disease | DISEASE | 2 |
| arterial hypertension | DISEASE | 2 |
| arterial dysfunction | DISEASE | 2 |
| arrhythmias | DISEASE | 2 |
| apomorphine | CHEMICAL | 2 |
| amyloid polypeptide | CHEMICAL | 2 |
| congenital deficiency | DISEASE | 2 |
| angiotensin i | CHEMICAL | 2 |
| angina | GPE | 2 |
| bupropion | CHEMICAL | 2 |
| atheroma | DISEASE | 2 |
| carbohydrates malabsorption | DISEASE | 2 |
| cardiovascular or renal disease | DISEASE | 2 |
| coagulopathy | DISEASE | 2 |
| chronicity | DISEASE | 2 |
| chronic renal disease | DISEASE | 2 |
| carcinoma | DISEASE | 2 |
| cognitive impairment | DISEASE | 2 |
| chronic obstructive pulmonary disease | DISEASE | 2 |
| chronic hepatitis b | DISEASE | 2 |
| chronic heart failure | DISEASE | 2 |
| choline | CHEMICAL | 2 |
| chemerin vaspin | ORG | 2 |
| central obesity | DISEASE | 2 |
| chronic kidney disease ckd | DISEASE | 2 |
| cardiac ion channelopathies | DISEASE | 2 |
| cardiometabolic diseases | DISEASE | 2 |
| cardiovascular morbimortality | DISEASE | 2 |
| cardiac injury | DISEASE | 2 |
| cardiac autonomic neuropathy | DISEASE | 2 |
| cardiac affection | DISEASE | 2 |
| cardiac hypertrophy | DISEASE | 2 |
| cardiotoxicity | DISEASE | 2 |
| colesterol | CHEMICAL | 2 |
| cardiovascular copd chronic obstructive pulmonary disease | DISEASE | 2 |
| cardiovascular metabolic diseases | DISEASE | 2 |
| landmark | PERSON | 1 |
| lage | GPE | 1 |
| lalic | TAXON | 1 |
| lambda | PERSON | 1 |
| laeeq ur rehman | PERSON | 1 |
| lan et al | PERSON | 1 |
| lancet | ORG | 1 |
| latin america latam | LOC | 1 |
| latin america cardiovascular disease | DISEASE | 1 |
| langerhans | GPE | 1 |
| lasertherapie ergaben | PERSON | 1 |
| latam multiple | ORG | 1 |
| latin america challenges and innovative solutions | ORG | 1 |
| latin america controlling | LOC | 1 |
| latin america diabetes | DISEASE | 1 |
| latin america evaluation | LOC | 1 |
| laborwerten | CHEMICAL | 1 |
| latin america global | LOC | 1 |
| latin america incidence | LOC | 1 |
| lactobacillus | GPE | 1 |
| lq | CHEMICAL | 1 |
| ly3298176 | CHEMICAL | 1 |
| lxra agonist | PERSON | 1 |
| lcacoa dag cer | ORG | 1 |
| ldl | PERSON | 1 |
| lav | ORG | 1 |
| latin american diabetes association racial | ORG | 1 |
| lada | ORG | 1 |
| ldl hdl | PERSON | 1 |
| ldl l5 | ORG | 1 |
| ldlox | ORG | 1 |
| ldo | ORG | 1 |
| lean | ORG | 1 |
| lep g 2548a | ORG | 1 |
| lga | ORG | 1 |
| lp fed | ORG | 1 |
| lpl | ORG | 1 |
| lsh l | ORG | 1 |
| lv | ORG | 1 |
| lvedd lvesd pwt | ORG | 1 |
| lvedd sw pw lvm | ORG | 1 |
| lvef | ORG | 1 |
| latin america registry | LOC | 1 |
| liver fat content in patients with inadequately controlled type 2 diabetes | ORG | 1 |
| latina | GPE | 1 |
| liver diseases easl | DISEASE | 1 |
| liver and pancreas fat | DISEASE | 1 |
| lnhoma | ORG | 1 |
| lombardy section italian | ORG | 1 |
| london london | PERSON | 1 |
| longa germplasm curcumin | PERSON | 1 |
| longa turmeric | PERSON | 1 |
| loop systems | ORG | 1 |
| lorubbio | CHEMICAL | 1 |
| lovecchio nicola | PERSON | 1 |
| low density lipoprotein cholesterol lowering with evolocumab | ORG | 1 |
| low fat diets | ORG | 1 |
| low fat high | PERSON | 1 |
| lowerextremityamputationratesinpeople | ORG | 1 |
| luana g | PERSON | 1 |
| lucidone | CHEMICAL | 1 |
| l auinitm g physical activity level | CHEMICAL | 1 |
| luciferaseimmunopräzipitationstest | CHEMICAL | 1 |
| lung injury | DISEASE | 1 |
| luminex | ORG | 1 |
| liver obesity | DISEASE | 1 |
| liver diseases | DISEASE | 1 |
| lazzarini peter najafi | PERSON | 1 |
| liver | GPE | 1 |
| lead pb | PERSON | 1 |
| leal | PERSON | 1 |
| leal l g | PERSON | 1 |
| lebanon | GPE | 1 |
| lebensjahr daten von 1995 | PERSON | 1 |
| leicester diabetes centre people | ORG | 1 |
| leishenshanwere | PERSON | 1 |
| lethal avian influenza | ORG | 1 |
| leukocyte | PERSON | 1 |
| leung | PERSON | 1 |
| león | GPE | 1 |
| libre view | ORG | 1 |
| libreview abbott diabetes care | ORG | 1 |
| lifestyle risk factors | ORG | 1 |
| lipogenesis | GPE | 1 |
| liposuction | ORG | 1 |
| lipotoxici ty | PERSON | 1 |
| lisco giuseppe | PERSON | 1 |
| liu zhelong bai xi | PERSON | 1 |
| l1 preadipocyte | PERSON | 1 |
| kennon b | CHEMICAL | 1 |
| l serine pathologically | PERSON | 1 |
| kapillarblutproben | PERSON | 1 |
| karen j kuc mph | PERSON | 1 |
| karnataka | GPE | 1 |
| karnataka kerala | PERSON | 1 |
| karnataka trends | PERSON | 1 |
| karolinska institute | ORG | 1 |
| kasralainy | CHEMICAL | 1 |
| kasralainy maternity | ORG | 1 |
| katam | PERSON | 1 |
| kato | PERSON | 1 |
| kchip2 | CHEMICAL | 1 |
| kchip2 kcnab1 | PERSON | 1 |
| kcna4 kcnj2 | CHEMICAL | 1 |
| kendall | PERSON | 1 |
| kenny | PERSON | 1 |
| kerala | GPE | 1 |
| ketoazidose unter | CHEMICAL | 1 |
| ketosis | GPE | 1 |
| khan | PERSON | 1 |
| khongrangjem | PERSON | 1 |
| kara b bonardo f peiretti | PERSON | 1 |
| kalorien hinaus | PERSON | 1 |
| l nielsen k a | CHEMICAL | 1 |
| kalliopi | CHEMICAL | 1 |
| jugendliche | CHEMICAL | 1 |
| jugendliche sie | PERSON | 1 |
| lxrb nfkb | CHEMICAL | 1 |
| jun | PERSON | 1 |
| jun fos pparg | PERSON | 1 |
| jun n | ORG | 1 |
| jun ppara | PERSON | 1 |
| k akt gsk 3beta | ORG | 1 |
| k akt | PERSON | 1 |
| k d modi 1 1 endocrinology | CHEMICAL | 1 |
| k senegalensis contains bioactive agents | CHEMICAL | 1 |
| ka | CHEMICAL | 1 |
| kauh | ORG | 1 |
| kcl | CHEMICAL | 1 |
| kdigo | ORG | 1 |
| kk | ORG | 1 |
| klf2 novel | ORG | 1 |
| kalantar kurosh | PERSON | 1 |
| kalesija | PERSON | 1 |
| kidney disease | DISEASE | 1 |
| kidney diseases | DISEASE | 1 |
| kidney diseases european medicines agency | ORG | 1 |
| kidney dysfunction | DISEASE | 1 |
| korean bmi | ORG | 1 |
| korean national health and nutrition examination survey | ORG | 1 |
| kosova | PERSON | 1 |
| kosova material | ORG | 1 |
| kostrzewa | GPE | 1 |
| kousathana | GPE | 1 |
| krakow | GPE | 1 |
| krankenhausentlassungsdaten | CHEMICAL | 1 |
| krankenhausentlassungsdaten von 2005 2015 | PERSON | 1 |
| krebsdextran | CHEMICAL | 1 |
| kulcsar ka | PERSON | 1 |
| kumpatla | PERSON | 1 |
| kurosh | CHEMICAL | 1 |
| kussmaul s | LOC | 1 |
| kutaisi | GPE | 1 |
| kuwait metabolic syndrome | GPE | 1 |
| l g | ORG | 1 |
| l garrido s | LOC | 1 |
| l name inhibitor | CHEMICAL | 1 |
| korea national health | ORG | 1 |
| korea health examinee study koex | ORG | 1 |
| kontrollgruppe wurde mit einer leitlinienorientierten | DISEASE | 1 |
| klebsiella liver abscess | CHEMICAL | 1 |
| kidney and liver damages | DISEASE | 1 |
| kidron 1 e arbit 2 1 oramed pharmaceuticals jerusalem israel 2 biomedical engineering nyu oramed pharmaceuticals englewood nj usa | CHEMICAL | 1 |
| kinesiology university of zagreb 3 vuk vrhovac university clinic zagreb croatia | ORG | 1 |
| king s | ORG | 1 |
| kit ldh | PERSON | 1 |
| kitchen | CHEMICAL | 1 |
| kjellsdotter et al 2020 | ORG | 1 |
| klebsiella infections | CHEMICAL | 1 |
| klinefelter | ORG | 1 |
| kontrollgruppe eine | DISEASE | 1 |
| klinefelter s syndrome | DISEASE | 1 |
| kluge | GPE | 1 |
| knochendichte bmd | PERSON | 1 |
| knockdown | PERSON | 1 |
| knowledge | PERSON | 1 |
| kochsalz | CHEMICAL | 1 |
| konsortium | CHEMICAL | 1 |
| konsortium wacdd | PERSON | 1 |
| lupus erythematosus | DISEASE | 1 |
| martz | GPE | 1 |
| lxrb nfkb srebf1 | PERSON | 1 |
| matabolic syndrome | LOC | 1 |
| maternal obesity | ORG | 1 |
| mathematical | ORG | 1 |
| matherial | ORG | 1 |
| matteoli maria c ciampalini | PERSON | 1 |
| matthew lee | PERSON | 1 |
| mauritius | ORG | 1 |
| mauritius diabetes care | ORG | 1 |
| maya | PERSON | 1 |
| mayo clinic | ORG | 1 |
| mbanya | CHEMICAL | 1 |
| mccoll kennedy | PERSON | 1 |
| mcgoogan 1 | ORG | 1 |
| measuring plantar tissue stress | ORG | 1 |
| mechanisms | PERSON | 1 |
| mechanisms of fibrosis development in nash | ORG | 1 |
| med hyg doi | PERSON | 1 |
| med prevalence | PERSON | 1 |
| medellı n colombia methods cross | ORG | 1 |
| medeniyet | CHEMICAL | 1 |
| maternal nutrition | ORG | 1 |
| mastroianni | CHEMICAL | 1 |
| medica sur hospital | ORG | 1 |
| masson s trichrome | PERSON | 1 |
| manitoba | GPE | 1 |
| mann whitney conclusions progression of ir | ORG | 1 |
| maori pacific | ORG | 1 |
| map creator 2 | PERSON | 1 |
| maracaibo | GPE | 1 |
| maracaibo venezuela | TAXON | 1 |
| maran | CHEMICAL | 1 |
| maran alberto busetto luca | PERSON | 1 |
| marco | CHEMICAL | 1 |
| marcus benjamin | PERSON | 1 |
| maria | PERSON | 1 |
| maria bonora benedetta selmin elisa | PERSON | 1 |
| maria buzzetti raffaella | PERSON | 1 |
| maria carvalho | PERSON | 1 |
| mariangela v | CHEMICAL | 1 |
| mario boscari federico fioretto | PERSON | 1 |
| mark bega harnik simone vieira de luca | PERSON | 1 |
| marseille france | PERSON | 1 |
| maslach anthropometric | PERSON | 1 |
| medeniyet university goztepe research | ORG | 1 |
| medical care in diabetes | ORG | 1 |
| lyme | GPE | 1 |
| meta analysis maternal depression and inflammation during pregnancy fruit | ORG | 1 |
| metabolic syndrome and related | PERSON | 1 |
| metabolic liver disease | DISEASE | 1 |
| metabolic syndrome metsy | DISEASE | 1 |
| metabolic syndrome diseases | DISEASE | 1 |
| method | PERSON | 1 |
| method blood | PERSON | 1 |
| method cross | ORG | 1 |
| method hyperlipidemia | PERSON | 1 |
| method receptor | PERSON | 1 |
| methodology a descriptive cross | ORG | 1 |
| methodology female | PERSON | 1 |
| methods a cross | ORG | 1 |
| methods alloxan | PERSON | 1 |
| methods analysis | ORG | 1 |
| methods brown | PERSON | 1 |
| methods comparative ms | ORG | 1 |
| methods data | ORG | 1 |
| joslin s diabetes mellitus 1 | ORG | 1 |
| methods euglycaemic | ORG | 1 |
| metab coronavirus infections | DISEASE | 1 |
| meta analysis diabetes management | ORG | 1 |
| medical isolation a qualitative study | ORG | 1 |
| meta analysis association of blood glucose control | ORG | 1 |
| medical pharmacology akdeniz university antalya turkey aims | ORG | 1 |
| medicina basada | PERSON | 1 |
| medicine cardiology massachusetts general hospital boston ma usa introduction obesity | ORG | 1 |
| medicine going | ORG | 1 |
| mellitus coronavirus | TAXON | 1 |
| mental health | ORG | 1 |
| mercuric chloride | CHEMICAL | 1 |
| mercury | ORG | 1 |
| mercury toxicity | DISEASE | 1 |
| meri seppo | PERSON | 1 |
| mesenchymal | GPE | 1 |
| metap psa hdm | ORG | 1 |
| mets logistic | ORG | 1 |
| mets prevention | ORG | 1 |
| mets development | ORG | 1 |
| mets folate | CHEMICAL | 1 |
| metsy patients | ORG | 1 |
| metsyn t b | DISEASE | 1 |